0001213900-18-015708.txt : 20181114 0001213900-18-015708.hdr.sgml : 20181114 20181114125530 ACCESSION NUMBER: 0001213900-18-015708 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST PATENT RESEARCH CORP CENTRAL INDEX KEY: 0000824416 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 112873662 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 033-18099-NY FILM NUMBER: 181182190 BUSINESS ADDRESS: STREET 1: 411 THEODORE FREMD AVE. STREET 2: SUITE 206S CITY: RYE STATE: NY ZIP: 10580 BUSINESS PHONE: 8887437577 MAIL ADDRESS: STREET 1: 411 THEODORE FREMD AVE. STREET 2: SUITE 206S CITY: RYE STATE: NY ZIP: 10580 FORMER COMPANY: FORMER CONFORMED NAME: QUEST PRODUCTS CORP DATE OF NAME CHANGE: 19971120 FORMER COMPANY: FORMER CONFORMED NAME: PHASE OUT OF AMERICA INC DATE OF NAME CHANGE: 19920703 10-Q 1 f10q0918_questpatent.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2018

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

QUEST PATENT RESEARCH CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

Delaware   33-18099-NY   11-2873662
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

411 Theodore Fremd Ave., Suite 206S, Rye, NY   10580-1411
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 743-7577

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. 383,038,334 shares of common stock are issued and outstanding as of November 14, 2018.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I - FINANCIAL INFORMATION  
Item 1. Financial Statements. 1
  Unaudited Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017 1
  Unaudited Consolidated Statements of Operations for the three and nine months ended September 30, 2018 and 2017 2
  Unaudited Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2017 3
  Notes to Unaudited Consolidated Financial Statements. 4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 14
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 20
Item 4. Controls and Procedures. 20
     
PART II - OTHER INFORMATION  
Item 6. Exhibits. 21

 

 

 

 

FORWARD LOOKING STATEMENTS

 

This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-looking statements.

 

Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the headings “Risks Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our report on Form 10-K for the year ended December 31, 2017, in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q and in other reports that we file with the SEC. You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.

 

We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

 

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this quarterly report, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

OTHER PERTINENT INFORMATION

 

Unless specifically set forth to the contrary, “Quest”, “Company”, “we,” “us,” “our” and similar terms refer to Quest Patent Research Corporation and its subsidiaries unless the context indicates otherwise.

 

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED BALANCE SHEETS

 

   September 30,
2018
   December 31,
2017
 
ASSETS        
         
Current assets        
Cash and cash equivalents  $37,589   $165,546 
Accounts receivable   6,050    2,846 
Other current assets   1,989    2,522 
Total current assets   45,628    170,914 
Patents, net of accumulated amortization of $983,850 and $650,560, respectively   2,150,048    2,463,338 
Total assets  $2,195,676   $2,634,252 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Liabilities          
Current liabilities:          
Accounts payable and accrued liabilities  $233,623    147,356 
Loans payable – third party   163,000    163,000 
Purchase price of patents, current portion   100,000    100,000 
Loan payable – related party, net of unamortized discount and debt issuance costs of $418,866 and $517,182, respectively   3,858,485    3,510,169 
Accrued interest – loans payable related party   395,459    85,757 
Accrued interest – loans payable third party   277,439    265,214 
Derivative liability   115,000    90,000 
Total current liabilities   5,143,006    4,361,496 
Non-current liabilities          
Purchase price of patents, current portion, net of unamortized discount of $123,321 and $175,243, respectively   751,679    699,757 
Total liabilities   5,894,685    5,061,253 
           
Stockholders’ deficit:          
Preferred stock – par value $.00003 per share – authorized 10,000,000 Shares – no shares issued and outstanding        
Common stock, par value $0.00003 per share; authorized 10,000,000,000 shares at September 30, 2018 and December 31, 2017, shares issued and outstanding 383,038,334 and 383,038,334, at September 30, 2018 and December 31, 2017   11,491    11,491 
Additional paid-in capital   14,107,782    14,107,782 
Accumulated deficit   (17,819,990)   (16,549,493)
Total Quest Patent Research Corporation deficit   (3,700,717)   (2,430,220)
Non-controlling interest in subsidiary   1,708    3,219 
Total stockholders’ deficit   (3,699,009)   (2,427,001)
Total liabilities and stockholders’ deficit  $2,195,676   $2,634,252 

 

See accompanying notes to unaudited consolidated financial statements.

 

1

 

 

QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS

 

   For the   For the 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2018   2017   2018   2017 
                 
Revenues                
Licensed Sales  $6,050   $2,846   $20,003   $8,509 
Patent licensing fees   -    575,000    7,049,000    1,196,250 
Management fees   -    -    -    24,302 
    6,050    577,846    7,069,003    1,229,061 
Operating expenses                    
Cost of revenue:                    
Cost of sales   1,095    377    3,689    1,449 
Litigation and licensing expenses   32,460    282,621    6,041,560    807,614 
Management support services   -    396    6,609    25,068 
Selling, general and administrative expenses   210,177    197,407    751,863    610,278 
                     
Total operating expenses   243,732    480,801    6,803,721    1,444,409 
                     
Income /(loss) from operations   (237,682)   97,045    265,282    (215,348)
                     
Other Income and (expenses)                    
Gain (loss) on derivative   (40,000)   (40,000)   (25,000)   40,000 
Interest expense   (165,382)   (194,833)   (472,165)   (426,860)
Total Other Income and (expenses)   (205,381)   (234,833)   (497,164)   (386,860)
                     
Net (loss) before income tax   (443,063)   (137,788)   (231,882)   (602,208)
                     
Income tax   -    (170)   (1,040,125)   (105,410)
                     
Net loss   (443,063)   (137,958)   (1,272,008)   (707,618)
Net income (loss) attributable to non-controlling interest in subsidiaries   485    21    1,511    (1,190)
Net loss attributable to Quest Patent Research Corporation  $(442,579)  $(137,937)  $(1,270,497)  $(708,808)
                     

Loss per share – basic and diluted

  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average shares outstanding – basic and diluted   383,038,334    313,038,334    383,038,334    313,038,334 

 

See accompanying notes to unaudited consolidated financial statements.

 

2

 

  

QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS

 

   For the 
   Nine Months Ended 
   September 30, 
   2018   2017 
         
Cash flows from operating activities:        
Net loss  $(1,272,008)  $(707,618)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of debt discounts   150,238    147,128 
Loss on monetization agreement   -    59,811 
Gain on derivative   25,000    (40,000)
Depreciation and amortization   333,290    226,846 
           
Changes in operating assets and liabilities          
Accounts receivable   (3,204)   38,358 
Accrued interest – loans payable related party   309,702    195,470 
Accrued interest – loans payable third party   12,225    12,225 
Other current assets   533    533 
Accounts payable and accrued expenses   86,267    1,464 
           
Net cash used in operating activities   (357,957)   (65,783)
           
Cash flows from investing activities          
Purchase of patents   (20,000)   - 
Net cash provided by investing activities   (20,000)   - 
           
Cash flows from financing activities          
Proceeds from loans-related party   250,000    - 
Net cash provided by financing activities   250,000    - 
           
Net decrease in cash and cash equivalents   (127,957)   (65,783)
           
Cash and cash equivalents at beginning of year   165,546    208,324 
           
Cash and cash equivalents at end of year  $37,589   $142,541 
           
Supplemental disclosure of cash flow information:          
Cash paid during the year for:          
Income taxes including foreign taxing authorities withheld taxes of $1,039,900 and $101,250 during the period ended September 30, 2018, and 2017 respectively.   1,040,125    105,410 
Interest   -    - 
Non-cash investing and financing activity:          
Loan proceeds paid directly from lender to seller of patents   -    25,000 
Accounts payable for purchase of patent, net of imputed interest of $202,522   -    772,478 

 

See accompanying notes to unaudited consolidated financial statements.

 

3

 

 

QUEST PATENT RESEARCH CORPORATION

 

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

 

NOTE 1 – DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

The Company is a Delaware corporation, incorporated on July 17, 1987 and has been engaged in the intellectual property monetization business since 2008.

 

As used herein, the “Company” refers to Quest Patent Research Corporation and its wholly and majority-owned and controlled operating subsidiaries unless the context indicates otherwise. All intellectual property acquisition, development, licensing and enforcement activities are conducted by the Company’s wholly and majority-owned and controlled operating subsidiaries.

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the US (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these interim financial statements do not include all of the information and notes required by GAAP for complete financial statements. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s consolidated financial position have been included. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2017. Operating results for the interim periods presented herein are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. Reclassifications from prior periods have been made to conform with the current year presentation.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of consolidation and financial statement presentation

 

The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and present the consolidated financial statements of the Company and its wholly-owned and majority owned subsidiaries as of September 30, 2018.

 

The consolidated financial statements include the accounts and operations of:

 

Quest Patent Research Corporation (“the Company”)
Quest Licensing Corporation (NY) (wholly-owned)
Quest Licensing Corporation (DE) (wholly-owned)
Quest Packaging Solutions Corporation (90% owned)
Quest Nettech Corporation (wholly-owned)
Semcon IP, Inc. (wholly-owned)
Mariner IC, Inc. (wholly-owned)
IC Kinetics, Inc. (wholly-owned)
CXT Systems, Inc. (wholly-owned)
Photonic Imaging Solutions Inc. (wholly-owned)

 

The operations of Wynn Technologies Inc. are not included in the Company’s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc. The sole asset of Wynn Technologies Inc. is US Patent No. RE38,137E. Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.

 

The Company accounts for its 65% interest in Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 60% share of income pursuant to the contractual agreement, which provides that Sol Li retains 40% of the income, and are reduced for distributions and its 60% share of losses incurred, respectively, with the restriction whereby the account balances cannot go below zero.

 

Significant intercompany transaction and balances have been eliminated in consolidation.

 

4

 

 

Use of Estimates

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Intangible Assets

 

Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent.

 

Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims that, based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

 

Derivative Financial Instruments

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black Scholes model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.

 

Fair value of financial instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for information about derivative liabilities.

 

5

 

 

The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. 

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.

 

Income Tax

 

The Company records revenues on a gross basis, before deduction for income taxes. The Company incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three and nine months ended September 30, 2018 and approximately $170 and approximately $105,000 for the three and nine months ended September 30, 2017.

 

Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses

 

In connection with the investment in certain patents and patent rights, certain of the Company’s operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

The Company’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded.

 

The Company’s operating subsidiaries may engage with funding sources that provide financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.

 

The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by the Company’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. The Company adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.

 

6

 

 

Recent Accounting Pronouncements

 

The Company is currently evaluating ASC 842 “Leases” for future adoption, which the Company will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. The Company does not believe that this guidance will affect its accounting.

 

Other than those pronouncements, management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on the Company’s financial statements.

 

Going Concern

 

As shown in the accompanying financial statements, the Company has an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. The Company generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by the Company’s subsidiaries that own the patents of their rights to the patents, which will further reduce the ability of the Company to generate revenue and the Company may be unable to continue in business. Because of the Company’s lack of a revenue stream, continuing losses, the working capital deficiency, the uncertainty of future revenue, the Company’s low stock price and the absence of a trading market in its common stock, the ability of the Company to raise funds in equity market or from lenders is severely impaired. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Although the Company may seek to raise funds and to obtain third party funding for litigation to enforce its intellectual property rights, the availability of such funds is uncertain and the disbursement of any such funds will be controlled by the lender. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 3 – SHORT-TERM DEBT AND LONG TERM LIABILITIES

 

The following table shows the Company’s short-term and long-term debt at September 30, 2018 and December 31, 2017.

 

   September 30,   December 31, 
   2018   2017 
Short-term debt:        
Loans payable – third party  $163,000   $163,000 
           
Loan payable – related party          
Gross   4,277,351    4,027,351 
Accrued Interest   395,459    85,757 
Unamortized discount   (418,866)   (517,182)
Net loans payable – related party  $4,253,944   $3,595,926 
Total short-term debt  $4,916,944   $3,758,926 
Long-term liabilities:          
Purchase price of patents          
Gross   875,000    875,000 
Unamortized discount   (123,321)   (175,243)
Net purchase price of patents – long-term  $751,679   $699,757 

 

The loan payable – third party is a demand loan made by former officers and directors, who are unrelated third parties at September 30, 2018 and December 31, 2017, in the amount of $163,000. The loans are payable on demand plus accrued interest at 10% per annum. These third parties are also shareholders, but their stockholdings are not significant. 

 

7

 

 

The loan payable – related party at September 30, 2018 represents the principal amount of the Company’s 10% note to United Wireless Holdings, Inc. (“United Wireless”) in the amount of $4,277,351 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. United Wireless was not a related party at the time of the loan. On March 16, 2017, the Company received a letter from counsel to United Wireless claiming that the Company is in violation of the requirements of the registration rights agreement dated October 22, 2015 on the grounds that the Company did not update the registration statement in November 2016. The Company disputed the claim that it was in breach of the registration rights agreement. On June 12, 2017, the Company entered into a standstill agreement with United Wireless pursuant to which the Company agreed (i) to increase its authorized common stock to 10,000,000,000 shares, (ii) to file by June 30, 2017, a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement, (iii) if the existing warrant held by the Company’s chief executive officer is not exercised prior to its expiration date, any re-issuance will not have an exercise price less than the current exercise price and the existing warrants will not be amended to lower the exercise price, and (iv) United Wireless no longer has any obligation to purchase any note pursuant to the securities purchase agreement other than the $1,000,000 note related to the final payment to Intellectual Ventures which was made in November 2017, except in connection with the potential acquisition by the Company of patent rights which triggered a $25,000 working capital loan in connection with the acquisition and the Company can require United Wireless to make $125,000 working capital loans to the Company, at the Company’s sole discretion, on December 31, 2017, March 31, 2018 and June 30, 2018 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 and, in such event, United Wireless would have a 7.5% net proceeds percentage interest in the net proceeds from such patent. On June 15, 2017, the Company amended its certificate of incorporation to increase its authorized common stock to 10,000,000,000 shares. On June 30, 2017, the Company filed a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement. The registration statement was declared effective on July 6, 2017. The Company issued to United Wireless a 10% promissory note due September 30, 2020 in the principal amount of $25,000 pursuant to the standstill agreement, for which the Company received $25,000, which was used to make the $25,000 advance to Intellectual Ventures Assets 34 LLC and Intellectual Ventures Assets 37 LLC (“IV 34/37”) as part of acquisition of intellectual property from IV 34/37. In connection with the loan, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT from IV 34/37. This obligation was recorded as an expense related to obtaining the standstill agreement and is reflected in interest expenses. CXT’s obligations under the monetization proceeds agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio. The security interest in the proceeds from the CXT Portfolio is junior to the security interest held by IV 34/37 in the CXT Portfolio and proceeds thereof. The notes payable to United Wireless have been classified as current liabilities as of September 30, 2018. Because of its right to elect a director of the Company under the securities purchase agreement, United Wireless is treated as a related party. Prior to the securities purchase agreement with United Wireless, the Company had no relationship with United Wireless.

 

Long-term liabilities

 

The purchase price of patents at September 30, 2018 represents the non-current portion of minimum payments due under the agreement between CXT Systems, Inc. (“CXT”), a wholly-owned subsidiary, and IV 34/37 pursuant to which at closing CXT acquired by assignment all right, title, and interest in a portfolio of fourteen United States patents, five foreign patents and six related applications (the “CXT Portfolio”). Under the agreement, CXT will distribute 50% of net recoveries, as defined, to IV 34/37. CXT advanced $25,000 to IV 34/37 at closing, and agreed that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/36. No affiliate of CXT has guaranteed the minimum payments. CXT’s obligations under the agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio.

 

8

 

 

NOTE 4 – DERIVATIVE LIABILITIES

 

Because there is not a fixed conversion price, the ability of the Company to remain compliant with the requirement under the United Wireless notes that the Company have sufficient authorized common stock in the event that the notes become convertible is outside of the control of the Company. There is no limit on the number of shares issuable under the note, and absent an increase in the stock price or an increase in authorized shares, it is possible the Company will not have enough authorized shares to satisfy the exercise of outstanding non-employee options and warrants. Thus, the Company determined the options and warrants qualify as derivative liabilities under ASC Topic 815. On January 22, 2016, the Company reclassified all non-employee warrants and options as derivative liabilities and revalued them at their fair values at each balance sheet date. Any change in fair value was recorded as other income (expense) for each reporting period at each balance sheet date. 

 

As of September 30, 2018, and December 31, 2017, the aggregate fair value of the outstanding derivative liability was approximately $115,000 and $90,000, respectively.

 

The Company estimated the fair value of the derivative liability using the Black-Scholes option pricing model using the following key assumptions during the period ended September 30, 2018:

 

   Period Ended
September 30,
 
   2018 
Volatility   417 % - 460%
Risk-free interest rate   1.36%
Expected dividends   -%
Expected term   2.00 – 2.75 years 

 

The following schedule summarizes the valuation of financial instruments at fair value in the balance sheets as of September 30, 2018 and December 31, 2017:

 

   Fair Value Measurements as of 
   September 30, 2018   December 31, 2017 
   Level 1   Level 2   Level 3   Level 1   Level 2   Level 3 
Assets                        
None   -    -    -    -    -    - 
Total assets   -    -    -    -    -    - 
Liabilities                              
Option derivative liability   -    -    115,000    -    -    90,000 
Total liabilities  $-   $-   $115,000   $-   $-   $90,000 

 

The following table sets forth a reconciliation of changes in the fair value of derivative liabilities classified as Level 3 in the fair value hierarchy:

 

   Significant Unobservable
Inputs
(Level 3)
as of
September 30, 2018
 
Beginning balance  $90,000 
Change in fair value   25,000 
Ending balance  $115,000 

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

Issuance of Common Stock and Options

 

There was no stock-based compensation expense for the nine months ended September 30, 2018 or 2017.

 

As of September 30, 2018, there was no unamortized option expense associated with compensatory options. 

 

9

 

 

A summary of the status of the Company’s stock options and changes is set forth below:

 

   Number of Options
(#)
   Weighted Average Exercise
Price ($)
   Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017   50,000,000    0.03    2.75 
Granted   -    -    - 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled   -    -    - 
Balance – September 30, 2018   50,000,000    0.03    2.00 

 

Warrants

 

As of September 30, 2018, there was no unamortized warrant expense.

 

A summary of the status of the Company’s stock warrants and changes is set forth below:

 

   Number of Warrants
(#)
   Weighted Average Exercise
Price ($)
   Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017   65,000,000    0.004    0.17 
Granted   -    -    - 
Cancelled   -    -    - 
Expired   65,000,000    0.004    - 
Exercised   -    -    - 
Balance – September 30, 2018   -    -    - 

 

NOTE 6 – INTANGIBLE ASSETS

 

Intangible assets include patents purchased and are recorded based at their acquisition cost. Intangible assets consisted of the following:

 

           Weighted
average
 
   September 30,   December 31,   amortization
period
 
   2018   2017   (years) 
Patents  $4,020,000   $4,000,000    9.8 
Less: net monetization obligations   (509,811)   (509,811)     
Imputed interest   (376,291)   (376,291)     
Subtotal   3,133,898    3,113,898      
Less: accumulated amortization   (983,850)   (650,560)     
Net value of intangible assets  $2,150,048   $2,463,338    8.2 

 

10

 

 

Intangible assets are comprised of patents with estimated useful lives. The intangible assets at September 30, 2018 represent: (1) patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years, (2) patents acquired in July 2017 pursuant to an obligation to distribute 50% of net revenues to IV 34/37, against which $25,000 was advanced at closing and provided that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions of 50% of net revenues to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/37; the useful lives of the patents, at the date of acquisition, was 5-6 years, (3) patents (which were fully depreciated at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC “(IV 62/71”), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71 against which CXT advanced $10,000 at closing; and (4) patents acquired in January 2018 by Photonic Imaging Solutions Inc. (“PIS”) from Intellectual Ventures Assets 64 LLC (“IV 64”) pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000, against which PIS advanced $10,000 at closing. The Company amortizes the costs of intangible assets over their estimated useful lives on a straight-line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included as a selling, general and administrative expense in the accompanying consolidated statements of operations.

 

The Company assesses intangible assets for any impairment to the carrying values. As of September 30, 2018, and December 31, 2017, management concluded that there was no impairment to the acquired assets. At September 30, 2018 and December 31, 2017, the net book value of the Company’s intellectual property was $2,150,048 and $2,463,338, respectively.

 

Amortization expense for patents comprised $333,290 and $331,275 for the nine months ended September 30, 2018 and the year ended December 31, 2017, respectively. Future amortization of intangible assets is as follows:

 

Year ended December 31,    
2018  $104,430 
2019   417,719 
2020   417,719 
2021   413,658 
2022 and thereafter   796,522 
Total  $2,150,048 

 

Pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, 15% of the net monetization proceeds from the patents acquired in October 2015 will be paid to the lender, United Wireless. This monetization obligation was recognized as a discount to the loan and is being amortized over the life of the loan using the effective interest method. In addition, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT in July 2017. This obligation was recorded as an expense and is reflected in interest expense during the third quarter of 2017. 

 

The Company granted IV 34/37 a security interest in the patents assigned to CXT as security for the payment of the balance of the purchase price. The security interest of IV 34/37 is senior to the security interest of United Wireless in the proceeds derived from such patents.

 

The balance of the purchase price of the patents is reflected as follows:

 

   September 30,
2018
   December 31,
2017
 
Current Liabilities:        
Purchase price of patents, current portion   100,000   $100,000 
Unamortized discount          
Non-current liabilities:          
Purchase price of patents, long term   875,000   $875,000 
Unamortized discount   (123,321)   (175,243)
Total current and non-current   851,679    799,757 
Effective interest rate of Amortized over 2-3 years        9.2-9.6%

 

Because the non-current minimum payment obligations of $875,000 are due over the next three years, the Company imputed interest of 10% and the interest will be accreted up to the maturity date. 

 

11

 

 

NOTE 7 – NON-CONTROLLING INTEREST

 

The following table reconciles equity attributable to the non-controlling interest related to Quest Packaging Solutions Corporation.

 

Balance as of December 31, 2017  $3,219 
Net income attributable to non-controlling interest  $(1,511)
Balance as of September 30, 2018  $1,708 

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

The Company has at various times entered into transactions with related parties, including officers, directors and major stockholders, pursuant to which, these related parties have provided services, advanced or loaned money, or both, to the Company needed to support its daily operations. The Company discloses all related party transactions.

 

See Notes 3 and 6 in connection with transactions with United Wireless. During the three- and nine-months ended September 30, 2018 and 2017, the Company incurred interest expense on the Company’s 10% notes issued to United Wireless pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. The interest expense was approximately $108,000 and $310,000 for the three- and nine-months ended September 30, 2018, respectively, and approximately $72,000 and $208,000 for the three- and nine-months ended September 30, 2017, respectively. On each of September 30, 2017 and 2018, accrued interest is added to the principal amount of the note.

 

During the three and nine months ended September 30, 2018 and 2017, the Company contracted with an entity owned by the chief technology officer for the provision of information technology services to the Company. The cost of such services was approximately $205 and $625 for the three and nine months ended September 30, 2018, respectively, and approximately $205 and $850 for the three and nine months ended September 30, 2017, respectively.

 

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

Employment Agreements

 

Pursuant to a restated employment agreement, dated November 30, 2014, with the Company’s president and chief executive officer, the Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days’ notice prior to the expiration of the initial term or any one-year extension. Pursuant to the agreement, the chief executive officer currently receives an annual salary to $300,000. The chief executive officer is entitled to a bonus if the Company meets or exceed performance criteria established by the compensation committee. In August 2016, the Company’s board of directors approved annual bonus compensation equal to 30% of the amount by which the Company’s consolidated income before income taxes exceeds $500,000, but, if the Company is subject to the limitation on deductibility of executive compensation pursuant to Section 162(m) of the Internal Revenue Code, the bonus cannot exceed the amount which would be deductible pursuant to Section 162(m). The chief executive officer is also eligible to participate in any executive incentive plans which the Company may adopt.

 

Inventor Royalties, Contingent Litigation Funding Fees and Contingent Legal Expenses

 

In connection with the investment in certain patents and patent rights, certain of the Company’s operating subsidiaries executed agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

12

 

 

The Company’s operating subsidiaries may engage third party funding sources to provide funding for patent licensing and enforcement. The agreements with the third-party funding sources may provide that the funding source receive a portion of any negotiated fees, settlements or judgments. In certain instances, these third-party funding sources are entitled to receive a significant percentage of any proceeds realized until the third-party funder has recouped agreed upon amounts based on formulas set forth in the underlying funding agreement, which may reduce or delay and proceeds due to the Company. 

 

The Company’s operating subsidiaries may retain the services of law firms in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby the law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

 

Depending on the amount of any recovery, it is possible that all the proceeds from a specific settlement may be paid to the funding source and legal counsel.

 

The economic terms of the inventor agreements, funding agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by the Company’s operating subsidiaries, if any, including royalty rates, proceeds sharing rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by the operating subsidiaries. Inventor royalties, payments to noncontrolling interests, payments to third party funding providers and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, payments to third party funding sources and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

 

In March 2014, the Company entered into a funding agreement whereby a third party agreed to provide funds to the Company to enable the Company to implement a structured licensing program, including litigation if necessary, for the Mobile Data. Under the funding agreement, the third party receives an interest in the proceeds from the program, and the Company has no other obligation to the third party. In April and June 2014, as part of a structured licensing program for the Mobile Data portfolio, Quest Licensing Corporation brought patent infringement suits in the U.S. District for the District of Delaware against Bloomberg LP et. al., FactSet Research Systems Inc., Interactive Data Corporation, SunGard Data Systems Inc. and The Charles Schwab Corporation et. al. These cases have been consolidated for trial. In June and August 2016, Quest Licensing Corporation entered into a settlement agreement with SunGard Data Systems Inc. and FactSet Research Systems Inc. As of the date of filing the third-party funder has advanced approximately $3,000,000 in litigation fees, costs and expenses. Under the terms of the funding agreement, the third-party funder is entitled to a priority return of funds advanced from any proceeds recovered. The Company’s management fees and management support services expenses relate to this agreement.

 

Patent Enforcement and Other Litigation

 

Certain of the Company’s operating subsidiaries are engaged in litigation to enforce their patents and patent rights. In connection with these patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against the Company or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by the Company or its operating subsidiaries, could materially harm the Company’s operating results and financial position and could result in a default under the Company’s loans. Since the operating subsidiaries do not have any assets other than the patents, and the Company does not have any available financial resources to pay any judgment which a defendant may obtain against a subsidiary, such a judgement may result in the bankruptcy of the subsidiary and/or the loss of the patents, which are the subsidiaries’ only assets.

 

On January 19, 2017, the court in the Mobile Data Portfolio litigation granted the defendants’ motion for summary judgment of non-infringement, which Quest Licensing Corporation has appealed. Following the court’s decision granting the defendant’s motion for summary judgment, the defendants moved for an award of attorneys’ fees under Section 285 of the Patent Act, which provides that “the court in exceptional cases may award reasonable attorney fees to the prevailing party.” Such a motion, if granted, would result in a judgment against Quest Licensing Corporation, which does not have the financial resources to enable it to pay any judgment which may be rendered against it, and, the defendants may seek to enforce their judgment by seeking to foreclose on the patents owned by the subsidiary or seek to force the subsidiary into bankruptcy and purchase the patents in the bankruptcy proceeding, either of which could result in a default under the Company’s agreement with United Wireless. The possible amount of any judgment cannot be estimated and the funding source for the litigation will not provide the Company with funds to pay an adverse judgment. On June 29, 2017, the defendants’ motion for attorney fees in the Mobile Data litigation was denied, without prejudice. Defendants may renew their motion thirty days from the decision of the appellate court. On June 8, 2018 the appellate court affirmed the lower court’s decision. On June 9, 2018 Quest Licensing Corporation filed a petition for rehearing with the appellate court. On July 30, 2018 the appellate court denied Quest Licensing Corporations petition for rehearing. On August 8, 2018, the defendants’ renewed their motion for an award of attorneys’ fees under Section 285 of the Patent Act.

 

13

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

Our principal operations include the development, acquisition, licensing and enforcement of intellectual property rights that are either owned or controlled by us or one of our wholly-owned subsidiaries. We currently own, control or manage ten intellectual property portfolios, which principally consist of patent rights. As part of our intellectual property asset management activities and in the ordinary course of our business, it has been necessary for either us or the intellectual property owner who we represent to initiate, and it is likely to continue to be necessary to initiate patent infringement lawsuits and engage in patent infringement litigation. To date, we have not generated any significant revenues from our intellectual property rights.

 

We seek to generate revenue from three sources:

 

  Patent licensing fees relating to our intellectual property portfolio, which includes fees from the licensing of our intellectual property, primarily from litigation relating to enforcement of our intellectual property rights, which were $0 for the nine months ended September 30, 2018 and represented more than 95% of our revenue for the nine months ended September 30, 2017.

 

  Management fees, which we receive for managing structured licensing programs, including litigation, related to our intellectual property rights. We did not generate any revenue from management fees during the three and nine months ended September 30, 2018 and we do not currently have any agreements that provide for the payment of management fees, and we may not be able to generate management fees in the future.

 

  Licensed packaging sales, which relate to the sale of licensed products, which accounted for insubstantial revenue during the three and nine months ended September 30, 2018 and 2017.

 

Because of the nature of our business transactions to date, we recognize revenues from licensing upon execution of a license agreement following settlement of litigation and not over the life of the patent. Thus, we would recognize revenue when we receive the license fee or settlement payment. Although we initially intended to seek to develop portfolios of intellectual property rights that provide us for a continuing stream of revenue, to date we have not been successful in doing so, and we do not anticipate that we will be able to generate any significant revenue from licenses that provide a continuing stream of revenue from our existing portfolios. Thus, to the extent that we continue to generate cash from single payment licenses, our revenue can, and is likely to, vary significantly from quarter to quarter and year to year. Our gross profit from license fees reflects any royalties which we pay in connection with our license. Because of our agreements with the funding sources and our litigation counsel, a significant percentage of our recovery is payable to our funding sources and counsel. We did not have any recovery in the three months ended September 30, 2018, although we incurred cost of revenues of $32,460 for the quarter. For the nine months ended September 30, 2018, approximately 85% of our recovery from patent license fees was paid to our funding sources and counsel. For the three and nine months ended September 30, 2017, approximately 49% and 68% of our recovery from patent license fees was paid to funding sources and counsel, respectively.

 

14

 

 

Fees generated in connection with the management of litigation were paid to us by one third-party funding source in support of the litigation seeking to enforce our intellectual property rights. Our agreement with the funding source provides that the funding source pays the litigation costs and provides that this funding source receives a percentage of the recovery, thus reducing our recovery in connection with any settlement of the litigation. As a result, in connection with litigation funded by the third party, we would, if the litigation is successful, receive fees both for managing the litigation, if the agreement with the funding source provides for such payments, and from a license of the intellectual property, which will be net of that portion of the recovery payable to the funding source. To the extent that we have agreements with counsel and/or litigation funding sources pursuant to which payments made to them represent a portion of the gross recovery, and such payment is contingent upon a recovery, our revenue from litigation reflects the gross recovery from litigation as licensing fees, and payments to counsel and/or litigation funding sources are reflected as cost of revenue.  

 

To a significantly lesser extent, we generate revenue from sale of packaging materials based on our TurtlePakTM technology. Our costs of sales represents the cost of contract manufacturing and labor. We did not generate any revenue from the TurtlePakTM Portfolio other than from the sale of products using our technology.

 

On January 19, 2017, the court in the Mobile Data Portfolio litigation granted the defendants’ motion for summary judgment of non-infringement, which Quest Licensing Corporation has appealed. Following the court’s decision granting the defendant’s motion for summary judgment, the defendants moved for an award of attorneys’ fees under Section 285 of the Patent Act which provides that “the court in exceptional cases may award reasonable attorney fees to the prevailing party.” Such a motion, if granted, would result in a judgment against Quest Licensing Corporation, which does not have the financial resources to enable it to pay any judgment which may be rendered against it, and, the defendants may seek to enforce their judgment by seeking to foreclose on the patents owned by the subsidiary or seek to force the subsidiary into bankruptcy and purchase the patents in the bankruptcy proceeding, either of which could result in a default under our agreements with United Wireless. On June 29, 2017, the defendants’ motion for attorney fees in the Mobile Data litigation was denied, without prejudice. The defendants may renew their motion thirty days from the decision of the appellate court. On June 8, 2018 the appellate court affirmed the lower court’s decision. On June 9, 2018, Quest Licensing Corporation filed a petition for rehearing with the appellate court. On July 30, 2018 the appellate court denied Quest Licensing Corporation’s petition for rehearing. On August 8, 2018, the defendants renewed their motion for an award of attorneys’ fees under Section 285 of the Patent Act.

 

In April 2016, Semcon IP Inc. brought patent infringement actions in the United States District Court for the Eastern District of Texas against Huawei Technologies, MediaTek Inc., STMicroelectronics Inc., Texas Instruments Incorporated and ZTE Corporation. As of September 30, 2018, these actions have been settled and dismissed. Our revenue for the three and nine months ended September 30, 2018 includes revenue from these settlements.

 

In May 2018 Semcon brought patent infringement actions in the United States District Court for the Eastern District of Texas against Amazon.com, Inc., ASUS TeK Computer Inc., TCL Communication Technology Holdings Limited et. al., Kyocera Corporation, LVMH Moet Hennessy Louis Vuitton, SE, Shenzhen OnePlus Science & Technology Co., Ltd., and Michael Kors Holdings Ltd.

 

In March 2018, Mariner IC brought patent infringement actions in the United States District Court for the Eastern District of Texas against Acer Inc., Schneider Electric, Sharp Corporation, AsusTek Computer Inc., and Bose Corporation. In April 2018, the actions against Acer Inc., Schneider Electric and Bose Corporation were dismissed. In April 2018, Mariner IC brought patent infringement actions in the United States District Court for the Eastern District of Texas against TiVo Corporation, Huawei Device Co., Ltd et. al., and Lenovo Group Ltd. In August 2018, the action against Huawei Device Co., Ltd et. al. was voluntarily dismissed. In September 2018, Mariner IC brought a patent infringement action in the United States District Court for the Eastern District of Texas against Huawei Device Co., Ltd et. al.

 

15

 

 

In April 2018 CXT brought patent infringement suits in the United States District Court for the Eastern District of Texas against Academy Ltd., The Container Store Group, Inc. and Pier 1 Imports, Inc.

 

In April 2018 PIS brought patent infringement actions in the United States District Court for the District of Delaware against Lenovo Group Ltd., AsusTek Computer Inc., Lorex Technology Inc., and NETGEAR, Inc.

 

On April 6, 2018, April 30, 2018 and July 2, 2018, we issued to United Wireless our 10% promissory note due September 30, 2020 in the principal amount of $25,000, $100,000 and $125,000 respectively, pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 and Note 3 to our financial statements included in this Form 10-Q, for which we received $25,000, $100,000 and $125,000 respectively.

 

Results of Operations

 

Three and nine months ended September 30, 2018 and 2017

 

Since revenues from patent licensing fees constitutes almost all of our revenue, our ability to generate revenues is dependent upon the generation of patent licensing fees. Since our ability to generate patent licensing fees is dependent upon a favorable settlement or judgement from legal actions we commence to enforce our intellectual property rights, our revenue stream can vary significantly from quarter to quarter. Typically, no revenues are generated until the litigation has proceeded for a considerable time, and, accordingly, it may take years from the date we commence litigation until we generate any revenues, and there is no assurance that we can or will generate revenues from our litigation. Defendants may file a motion to dismiss which may be, and in some cases has been granted, Thus there may be many quarters during we do not generate any revenue from patent licensing fees, which is currently, the only source of revenue other than nominal sales of TurtlePak. The quarter ended September 30, 2018, was such a quarter, as we did not generate any revenue form patent licensing fees, as contrasted with patent licensing fees of $575,000 for the three months ended September 30, 2017.

 

For the nine months ended September 30, 2018, our revenues were approximately $7,069,000, of which approximately $7,049,000 represented patent licensing fees, as compared with revenues of approximately $1,229,000 for the nine months ended September 30, 2017, of which approximately $1,196,000 was from patent licensing fees. Because the settlements represent one-time payments, the timing and receipt of which cannot be predicted or planned, the timing of our revenue is dependent upon the timing of any settlements of litigation with no assurance as to when or whether any action will be settled in a manner which generates either revenue or cash flow to us.

 

Operating expenses for the three months ended September 30, 2018 decreased by approximately $237,000, or 49%, compared to the three months ended September 30, 2017. Operating expenses for the nine months ended September 30, 2018 increased by approximately $5,359,000, or 371%, compared to the nine months ended September 30, 2017. Our principal operating expense for the three-months ended September 30, 2018 was executive compensation, which was approximately $85,500. Our principal operating expense for the nine-months ended September 30, 2018 was litigation and licensing expenses of approximately $6,042,000, which represent fees payable to attorneys and third-party funding sources associated with the power management portfolio settlements, representing approximately 86% of our license fees. These fees became payable as a result of settlement agreements that provided for a recovery. The total settlement recovery is included in revenue and the associated costs are treated as cost of revenue. When the settlement funds are disbursed we receive the net amount due us after deducting the associated settlement costs. We had litigation and licensing expenses of approximately $283,000 and approximately $808,000 for the three- and nine-months ended September 30, 2017, respectively.

 

Other income (expense) included interest expense of approximately $165,000 and approximately $472,000 for the three- and nine-months ended September 30, 2018, respectively, and approximately $195,000 and approximately $427,000 for the three- and nine-months ended September 30, 2017, respectively. The increase in interest expense primarily reflect the accrued interest on our note to United Wireless, which was added to the principal amount of the note on September 30, 2018.

 

During the period we incurred income tax expense of approximately $0 and approximately $1,040,000 for the three- and nine-months ended September 30, 2018, respectively, compared to $170 and $105,000 for the three- and nine-months ended September 30, 2017, respectively. The increase in income tax expense primarily reflect foreign income taxes related to foreign source patent fees.

 

As a result of the foregoing, we sustained a net loss of approximately $443,000, or $0.00 per share (basic and diluted), for the three months ended September 30, 2018 and a net loss of approximately $1,270,000, or $0.00 per share (basic and diluted), for the nine months ended September 30, 2018, compared to net loss of approximately $138,000, or $0.00 per share (basic and diluted), for the three months ended September 30, 2017 and a net loss of approximately $709,000, or $0.00 per share (basic and diluted), for the nine months ended September 30, 2017.

 

16

 

 

Liquidity and Capital Resources

 

At September 30, 2018, we had current assets of approximately $46,000, and current liabilities of approximately $5,143,000. Our current liabilities include $4,253,000 due to United Wireless, $100,000 payment due to Intellectual Ventures on account of the purchase price of the patent portfolios we purchased from IV 34/37 and loans payable of $163,000 and accrued interest of approximately $277,000 due to former directors and minority stockholders. As of September 30, 2018, we have an accumulated deficit of approximately $17,820,000 and a negative working capital of approximately $5,097,000. Other than salary to our chief executive officer and expenses, primarily legal and accounting, relating to our status as a public company, we do not contemplate any other material operating expense in the near future other than normal general and administrative expenses.

 

We cannot assure you that we will be successful in generating revenues, in obtaining additional debt or equity financing or that such additional debt or equity financing will be available on terms acceptable to us, if at all, or that we will be able to obtain any third-party funding in connection with any of our intellectual property portfolios. We have no credit facilities. 

 

We have an agreement with a funding source which is providing litigation financing in connection with our pending litigation relating to our mobile data portfolio, and we have two agreements with a second funding source which is providing litigation financing in connection with our pending litigation relating to our power management/bus control and anchor structure portfolios. We cannot predict the success of any pending or future litigation.

 

Our obligations to United Wireless are not contingent upon the success of any litigation. If we fail to generate a sufficient recovery in any of our pending actions (net of any portion of any recovery payable to the funding source or our legal counsel) in a timely manner to enable us to meet our obligations to United Wireless on the loans made to us, we would be in default under our agreements with United Wireless which could result in United Wireless foreclosing on the patent rights which secure the debt, which may result in the loss by our subsidiaries that own the patents of their rights to the patents, which will further reduce our ability to generate revenue and we may be unable to continue in business. Our agreements with the funding sources provide that the funding sources will participate in any recovery which is generated. We believe that our financial condition, our history of losses and negative cash flow from operations, and our low stock price make it difficult for us to raise funds in the debt or equity markets.

 

As noted below, there is a substantial doubt about our ability to continue as a going concern.

 

Significant Accounting Policies and Estimates

 

The discussion and analysis of our financial condition and results of operations is based upon our financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities. On an on-going basis, we evaluate our estimates including the allowance for doubtful accounts, the salability and recoverability of our products, income taxes and contingencies. We base our estimates on historical experience and on other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Management believes the following critical accounting policies affect the significant judgments and estimates used in the preparation of the financial statements.

 

Principles of Consolidation

 

The consolidated financial statements are prepared in accordance with US GAAP and present the financial statements of the Company and our wholly-owned subsidiary. In the preparation of our consolidated financial statements, intercompany transactions and balances are eliminated.

 

17

 

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Fair Value of Financial Instruments

 

We adopted Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures”, for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing US GAAP that require the use of fair value measurements which establishes a framework for measuring fair value and expands disclosure about such fair value measurements. 

 

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

 

  Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities
     
  Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data
     
  Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

In addition, FASB ASC 825-10-25 “Fair Value Option” was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value.

 

Income Tax

 

We record revenues on a gross basis, before deduction for income taxes. We incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three- and nine-months ended September 30, 2018, respectively, and approximately $170 and approximately $105,000 for the three- and nine-months ended September 30, 2017, respectively.

 

Long-Lived Assets

 

We review for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable, pursuant to guidance established in ASC 360-10-35-15, “Impairment or Disposal of Long-Lived Assets”. We recognize an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.

 

Revenue Recognition

 

We recognize revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. We adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.

 

18

 

 

Cost of Revenue

 

Cost of revenues mainly includes expenses incurred in connection with our patent enforcement activities, such as legal fees, consulting costs, patent maintenance, royalty fees for acquired patents and other related expenses. Cost of revenue does not include expenses related to product development, patent amortization, integration or support, as these are included in general and administrative expenses.

 

Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses

 

In connection with the investment in certain patents and patent rights, certain of our operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

Our operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded. 

 

Our operating subsidiaries may engage with funding sources that specialize in providing financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.

 

The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors. To the extent that we have agreements with counsel and/or litigation funding sources pursuant to which payments made to them represent a portion of the gross recovery, and such payment is contingent upon a recovery, our revenue from litigation reflects the gross recovery from litigation as licensing fees, and payments to counsel and/or litigation funding sources are reflected as cost of revenue.

 

Recent Accounting Pronouncements

 

We are currently evaluating ASC 842 “Leases” for future adoption, which we will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. We do not believe that this guidance will affect our accounting.

 

Management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on our financial statements.

 

Going Concern

 

We have an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. We generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by our subsidiaries that own the patents of their rights to the patents, which will further reduce our ability to generate revenue and we may be unable to continue in business. Because of our lack of a revenue stream, continuing losses, our working capital deficiency, the uncertainty of future revenue, our obligations to Intellectual Ventures and United Wireless, our low stock price and the absence of a trading market in our common stock, our ability to raise funds in equity market or from lenders is severely impaired, and we may not be able to continue as a going concern. Although we may seek to raise funds and to obtain third party funding for litigation to enforce our intellectual property rights, the availability of such funds in uncertain and the disbursement of any such funds will be controlled by the lender. Further, the funding sources do not cover any liability which we may incur in the event that we do not prevail in litigation and we are required to pay the defendant’s legal costs or a judgment against us by a defendant. In the event of a judgment against any of our subsidiaries, it may be necessary for the subsidiary to seek protection under the Bankruptcy Act, which could result in a default under our notes to United Wireless. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

19

 

 

Off-balance Sheet Arrangements

 

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholder’s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item. 

 

Item 4. Controls and Procedures.

 

Management’s Conclusions Regarding Effectiveness of Disclosure Controls and Procedures

 

We conducted an evaluation of the effectiveness of our “disclosure controls and procedures” (“Disclosure Controls”), as defined by Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2018, the end of the period covered by this Quarterly Report on Form 10-Q. The Disclosure Controls evaluation was done under the supervision and with the participation of management, including our chief executive officer and chief financial officer, which positions are held by the same person. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon this evaluation, our chief executive officer and chief financial officer concluded that, due to the inadequacy of our internal controls over financial reporting, our sole employee being our chief executive and financial officer and our limited internal audit function, our disclosure controls were not effective as of September 30, 2018, such that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to the president and treasurer, as appropriate to allow timely decisions regarding disclosure.

 

Changes in Internal Control over Financial Reporting.

 

As reported in our annual report on Form 10-K for the year ended December 31, 2017, management has determined that our internal audit our internal controls contains material weaknesses due to insufficient segregation of duties within accounting functions as well as lack of qualified accounting personnel and excessive reliance on third party consultants for accounting, financial reporting and related activities. These problems continue to affect us as we only have one full-time executive officer, who is our only full-time employee and who serves as chief executive officer and chief financial officer.

 

During the period ended September 30, 2018, there was no change in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

20

 

 

PART II - OTHER INFORMATION

 

Item 6. Exhibits.

 

31.1 Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.ins XBRL Instance Document
101.sch XBRL Taxonomy Schema Document
101.cal XBRL Taxonomy Calculation Document
101.def XBRL Taxonomy Linkbase Document
101.lab XBRL Taxonomy Label Linkbase Document
101.pre XBRL Taxonomy Presentation Linkbase Document

 

21

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 14, 2018

 

  QUEST PATENT RESEARCH CORPORATION
     
  By: /s/ Jon C. Scahill
    Jon C. Scahill
    Chief executive officer and
acting chief financial officer

 

22

EX-31.1 2 f10q0918ex31-1_questpatent.htm CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Jon C. Scahill, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Quest Patent Research Corporation;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
     
  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     
  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

a)all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

   

Dated:  November 14, 2018 By: /s/ Jon C. Scahill
    Chief Executive Officer and
Acting Chief Financial Officer)
    (Principal Executive and Accounting Officer)

  

EX-32.1 3 f10q0918ex32-1_questpatent.htm CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

  

In connection with the Quarterly Report of Quest Patent Research Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon C. Scahill, chief executive officer and acting chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Date: November 14, 2018   By: /s/ Jon C. Scahill
    Jon C. Scahill
    Chief Executive Officer and
Acting Chief Financial Officer
    (Principal Executive and Accounting Officer)

  

EX-101.INS 4 qprc-20180930.xml XBRL INSTANCE FILE 0000824416 us-gaap:ChiefExecutiveOfficerMember 2014-11-29 2014-11-30 0000824416 2015-10-01 2015-10-31 0000824416 us-gaap:ChiefExecutiveOfficerMember 2016-03-01 2016-03-31 0000824416 us-gaap:ChiefExecutiveOfficerMember 2016-08-01 2016-08-31 0000824416 2016-12-31 0000824416 qprc:StandstillAgreementMember qprc:UnitedWirelessHoldingsMember 2017-06-01 2017-06-12 0000824416 qprc:SecuritiesPurchaseAgreementMember qprc:UnitedWirelessHoldingsMember 2017-06-15 0000824416 2017-06-30 0000824416 2017-07-01 2017-09-30 0000824416 2017-01-01 2017-09-30 0000824416 2017-09-30 0000824416 2017-01-01 2017-12-31 0000824416 us-gaap:PatentsMember srt:MaximumMember 2017-01-01 2017-12-31 0000824416 us-gaap:PatentsMember srt:MinimumMember 2017-01-01 2017-12-31 0000824416 us-gaap:WarrantMember 2017-01-01 2017-12-31 0000824416 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0000824416 2017-12-31 0000824416 us-gaap:WarrantMember 2017-12-31 0000824416 us-gaap:EmployeeStockOptionMember 2017-12-31 0000824416 us-gaap:FairValueInputsLevel3Member 2017-12-31 0000824416 us-gaap:FairValueInputsLevel1Member 2017-12-31 0000824416 us-gaap:FairValueInputsLevel2Member 2017-12-31 0000824416 us-gaap:PatentsMember 2017-12-31 0000824416 2018-07-01 2018-09-30 0000824416 2018-01-01 2018-09-30 0000824416 us-gaap:PatentsMember srt:MaximumMember 2018-01-01 2018-09-30 0000824416 us-gaap:PatentsMember srt:MinimumMember 2018-01-01 2018-09-30 0000824416 us-gaap:WarrantMember 2018-01-01 2018-09-30 0000824416 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0000824416 us-gaap:FairValueInputsLevel3Member 2018-01-01 2018-09-30 0000824416 us-gaap:PatentsMember 2018-01-01 2018-09-30 0000824416 qprc:StandstillAgreementMember 2018-01-01 2018-09-30 0000824416 qprc:WynnTechnologiesMember 2018-01-01 2018-09-30 0000824416 srt:MaximumMember 2018-01-01 2018-09-30 0000824416 srt:MinimumMember 2018-01-01 2018-09-30 0000824416 qprc:UnitedWirelessHoldingsMember 2018-01-01 2018-09-30 0000824416 2018-09-30 0000824416 qprc:SecuritiesPurchaseAgreementMember qprc:UnitedWirelessHoldingsMember 2018-09-30 0000824416 us-gaap:WarrantMember 2018-09-30 0000824416 us-gaap:EmployeeStockOptionMember 2018-09-30 0000824416 us-gaap:FairValueInputsLevel3Member 2018-09-30 0000824416 us-gaap:FairValueInputsLevel1Member 2018-09-30 0000824416 us-gaap:FairValueInputsLevel2Member 2018-09-30 0000824416 us-gaap:PatentsMember 2018-09-30 0000824416 qprc:StandstillAgreementMember 2018-09-30 0000824416 qprc:WynnTechnologiesMember 2018-09-30 0000824416 qprc:QuestPackagingSolutionsCorporationMember 2018-09-30 0000824416 2018-11-14 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure QUEST PATENT RESEARCH CORP 0000824416 QPRC false --12-31 10-Q 2018-09-30 Q3 2018 Non-accelerated Filer true false false 383038334 208324 14372 142541 165546 37589 2846 6050 2522 1989 170914 45628 2463338 2150048 2634252 2195676 147356 233623 163000 163000 100000 100000 100000 100000 3510169 3858485 85757 395459 265214 277439 90000 115000 4361496 5143006 699757 751679 5061253 5894685 11491 11491 14107782 14107782 -16549493 -17819990 -2430220 -3700717 3219 1708 -2427001 -3699009 2634252 2195676 650560 983850 517182 418866 175243 123321 0.00003 0.00003 10000000 10000000 0.00003 0.00003 10000000000 10000000000 10000000000 383038334 383038334 383038334 383038334 2846 8509 6050 20003 575000 1196250 7049000 24302 577846 1229061 6050 7069003 377 1449 1095 3689 282621 807614 32460 6041560 396 25068 6609 197407 610278 210177 751863 480801 1444409 243732 6803721 97045 -215348 -237682 265282 -40000 40000 -40000 -25000 194833 426860 165382 472165 -234833 -386860 -205381 -497164 -137788 -602208 -443063 -231882 170 105410 1040125 -137958 -707618 -443063 -1272008 -21 1190 -485 -1511 -137937 -708808 -442579 -1270497 -0.00 -0.00 -0.00 -0.00 313038334 313038334 383038334 383038334 147128 150238 59811 40000 -25000 226846 333290 -38358 3204 195470 309702 12225 12225 -533 -533 1464 86267 -65783 -357957 20000 -20000 250000 250000 -65783 -127957 105410 1040125 25000 772478 101250 1039900 202522 <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company is a Delaware corporation, incorporated on July 17, 1987 and has been engaged in the intellectual property monetization business since 2008.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">As used herein, the &#8220;Company&#8221; refers to Quest Patent Research Corporation and its wholly and majority-owned and controlled operating subsidiaries unless the context indicates otherwise. All intellectual property acquisition, development, licensing and enforcement activities are conducted by the Company&#8217;s wholly and majority-owned and controlled operating subsidiaries.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the US (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these interim financial statements do not include all of the information and notes required by GAAP for complete financial statements. All adjustments (consisting of normal recurring items) necessary to present fairly the Company&#8217;s consolidated financial position have been included. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2017. Operating results for the interim periods presented herein are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. Reclassifications from prior periods have been made to conform with the current year presentation.</font></p></div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Principles of consolidation and financial statement presentation</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (&#8220;US GAAP&#8221;) and present the consolidated financial statements of the Company and its wholly-owned and majority owned subsidiaries as of September 30, 2018.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The consolidated financial statements include the accounts and operations of:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 1519px; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Patent Research Corporation (&#8220;the Company&#8221;)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Licensing Corporation (NY) (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Licensing Corporation (DE) (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Packaging Solutions Corporation (90% owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Nettech Corporation (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Semcon IP, Inc. (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Mariner IC, Inc. (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">IC Kinetics, Inc. (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">CXT Systems, Inc. (wholly-owned)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Photonic Imaging Solutions Inc. (wholly-owned)</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The operations of Wynn Technologies Inc. are not included in the Company&#8217;s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc. The sole asset of Wynn Technologies Inc. is US Patent No. RE38,137E. Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company accounts for its 65% interest in Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 60% share of income pursuant to the contractual agreement, which provides that Sol Li retains 40% of the income, and are reduced for distributions and its 60% share of losses incurred, respectively, with the restriction whereby the account balances cannot go below zero.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Significant intercompany transaction and balances have been eliminated in consolidation.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Use of Estimates</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Intangible Assets</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Patents include the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims that, based on management&#8217;s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Derivative Financial Instruments</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black Scholes model, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221; to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Fair value of financial instruments</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for information about derivative liabilities.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 1</i>&#160;&#8211; Quoted prices in active markets for identical assets or liabilities.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 2</i>&#160;&#8211; Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 3</i>&#160;&#8211; Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Income Tax</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company records revenues on a gross basis, before deduction for income taxes. The Company incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three and nine months ended September 30, 2018 and approximately $170 and approximately $105,000 for the three and nine months ended September 30, 2017.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In connection with the investment in certain patents and patent rights, certain of the Company&#8217;s operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may engage with funding sources that provide financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by the Company&#8217;s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Revenue Recognition</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company recognizes revenue in accordance with ASC Topic 606, &#8220;Revenue from Contracts with Customers&#8221;. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. The Company adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Recent Accounting Pronouncements</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company is currently evaluating ASC 842 &#8220;Leases&#8221; for future adoption, which the Company will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. The Company does not believe that this guidance will affect its accounting.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Other than those pronouncements, management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Going Concern</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">As shown in the accompanying financial statements, the Company has an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. The Company generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by the Company&#8217;s subsidiaries that own the patents of their rights to the patents, which will further reduce the ability of the Company to generate revenue and the Company may be unable to continue in business. Because of the Company&#8217;s lack of a revenue stream, continuing losses, the working capital deficiency, the uncertainty of future revenue, the Company&#8217;s low stock price and the absence of a trading market in its common stock, the ability of the Company to raise funds in equity market or from lenders is severely impaired. These conditions raise substantial doubt as to the Company&#8217;s ability to continue as a going concern. Although the Company may seek to raise funds and to obtain third party funding for litigation to enforce its intellectual property rights, the availability of such funds is uncertain and the disbursement of any such funds will be controlled by the lender. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> </div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 3 &#8211; SHORT-TERM DEBT AND LONG TERM LIABILITIES</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The following table shows the Company&#8217;s short-term and long-term debt at September 30, 2018 and December 31, 2017.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; font-size-adjust: none; font-stretch: normal;" colspan="2">September&#160;30,</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; font-size-adjust: none; font-stretch: normal;" colspan="2">December&#160;31,</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;" colspan="2">2018</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;" colspan="2">2017</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Short-term debt:</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 1191px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Loans payable &#8211; third party</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">163,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">163,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Loan payable &#8211; related party</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Gross</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">4,277,351</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">4,027,351</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Accrued Interest</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">395,459</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">85,757</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">Unamortized discount</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(418,866</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(517,182</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Net loans payable &#8211; related party</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">4,253,944</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">3,595,926</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Total short-term debt</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">4,916,944</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">3,758,926</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Long-term liabilities:</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Purchase price of patents</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Gross</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">875,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">875,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">Unamortized discount</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(123,321</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(175,243</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Net purchase price of patents &#8211; long-term</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">751,679</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">699,757</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The loan payable &#8211; third party is a demand loan made by former officers and directors, who are unrelated third parties at September 30, 2018 and December 31, 2017, in the amount of $163,000. The loans are payable on demand plus accrued interest at 10% per annum. These third parties are also shareholders, but their stockholdings are not significant.&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The loan payable &#8211; related party at September 30, 2018 represents the principal amount of the Company&#8217;s 10% note to United Wireless Holdings, Inc. (&#8220;United Wireless&#8221;) in the amount of $4,277,351 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017. United Wireless was not a related party at the time of the loan. On March 16, 2017, the Company received a letter from counsel to United Wireless claiming that the Company is in violation of the requirements of the registration rights agreement dated October 22, 2015 on the grounds that the Company did not update the registration statement in November 2016. The Company disputed the claim that it was in breach of the registration rights agreement. On June 12, 2017, the Company entered into a standstill agreement with United Wireless pursuant to which the Company agreed (i) to increase its authorized common stock to 10,000,000,000 shares, (ii) to file by June 30, 2017, a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement, (iii) if the existing warrant held by the Company&#8217;s chief executive officer is not exercised prior to its expiration date, any re-issuance will not have an exercise price less than the current exercise price and the existing warrants will not be amended to lower the exercise price, and (iv) United Wireless no longer has any obligation to purchase any note pursuant to the securities purchase agreement other than the $1,000,000 note related to the final payment to Intellectual Ventures which was made in November 2017, except in connection with the potential acquisition by the Company of patent rights which triggered a $25,000 working capital loan in connection with the acquisition and the Company can require United Wireless to make $125,000 working capital loans to the Company, at the Company&#8217;s sole discretion, on December 31, 2017, March 31, 2018 and June 30, 2018 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017 and, in such event, United Wireless would have a 7.5% net proceeds percentage interest in the net proceeds from such patent. On June 15, 2017, the Company amended its certificate of incorporation to increase its authorized common stock to 10,000,000,000 shares. On June 30, 2017, the Company filed a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement. The registration statement was declared effective on July 6, 2017. The Company issued to United Wireless a 10% promissory note due September 30, 2020 in the principal amount of $25,000 pursuant to the standstill agreement, for which the Company received $25,000, which was used to make the $25,000 advance to Intellectual Ventures Assets 34 LLC and Intellectual Ventures Assets 37 LLC (&#8220;IV 34/37&#8221;) as part of acquisition of intellectual property from IV 34/37. In connection with the loan, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT from IV 34/37. This obligation was recorded as an expense related to obtaining the standstill agreement and is reflected in interest expenses. CXT&#8217;s obligations under the monetization proceeds agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio. The security interest in the proceeds from the CXT Portfolio is junior to the security interest held by IV 34/37 in the CXT Portfolio and proceeds thereof. The notes payable to United Wireless have been classified as current liabilities as of September 30, 2018. Because of its right to elect a director of the Company under the securities purchase agreement, United Wireless is treated as a related party. Prior to the securities purchase agreement with United Wireless, the Company had no relationship with United Wireless.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Long-term liabilities</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The purchase price of patents at September 30, 2018 represents the non-current portion of minimum payments due under the agreement between CXT Systems, Inc. (&#8220;CXT&#8221;), a wholly-owned subsidiary, and IV 34/37 pursuant to which at closing CXT acquired by assignment all right, title, and interest in a portfolio of fourteen United States patents, five foreign patents and six related applications (the &#8220;CXT Portfolio&#8221;). Under the agreement, CXT will distribute 50% of net recoveries, as defined, to IV 34/37. CXT advanced $25,000 to IV 34/37 at closing, and agreed that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/36. No affiliate of CXT has guaranteed the minimum payments. CXT&#8217;s obligations under the agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio.</font></p> </div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 4 &#8211; DERIVATIVE LIABILITIES</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Because there is not a fixed conversion price, the ability of the Company to remain compliant with the requirement under the United Wireless notes that the Company have sufficient authorized common stock in the event that the notes become convertible is outside of the control of the Company. There is no limit on the number of shares issuable under the note, and absent an increase in the stock price or an increase in authorized shares, it is possible the Company will not have enough authorized shares to satisfy the exercise of outstanding non-employee options and warrants. Thus, the Company determined the options and warrants qualify as derivative liabilities under ASC Topic 815. On January 22, 2016, the Company reclassified all non-employee warrants and options as derivative liabilities and revalued them at their fair values at each balance sheet date. Any change in fair value was recorded as other income (expense) for each reporting period at each balance sheet date.&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">As of September 30, 2018, and December 31, 2017, the aggregate fair value of the outstanding derivative liability was approximately $115,000 and $90,000, respectively.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company estimated the fair value of the derivative liability using the Black-Scholes option pricing model using the following key assumptions during the period ended September 30, 2018:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2">Period Ended&#160;<br />September&#160;30,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td>Volatility</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">417 % - 460</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 1379px; text-align: left;">Risk-free interest rate</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">&#160;</td> <td style="width: 141px; text-align: right;">1.36</td> <td style="width: 15px; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Expected dividends</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Expected term</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right; white-space: nowrap;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">2.00 &#8211; 2.75&#160;years</font></td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The following schedule summarizes the valuation of financial instruments at fair value in the balance sheets as of September 30, 2018 and December 31, 2017:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="22">Fair Value Measurements as of</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">September 30, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2017</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-weight: bold;">Assets</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1.5pt;">None</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Total assets</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-weight: bold;">Liabilities</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 439px; text-align: left; padding-bottom: 1.5pt;">Option derivative liability</td> <td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">115,000</td> <td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">90,000</td> <td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 4pt;">Total liabilities</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">115,000</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">90,000</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The following table sets forth a reconciliation of changes in the fair value of derivative liabilities classified as Level 3 in the fair value hierarchy:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant Unobservable<br />Inputs<br />(Level&#160;3)<br />as of<br />September&#160;30, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1379px; text-align: justify;">Beginning balance</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">90,000</td> <td style="width: 15px; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify; padding-bottom: 1.5pt;">Change in fair value</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">25,000</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 4pt;">Ending balance</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">115,000</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> </div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 5 &#8211; STOCKHOLDERS&#8217; EQUITY</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Issuance of Common Stock and Options</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">There was no stock-based compensation expense for the nine months ended September 30, 2018 or 2017.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">As of September 30, 2018, there was no unamortized option expense associated with compensatory options.&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">A summary of the status of the Company&#8217;s stock options and changes is set forth below:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Options<br />(#)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise<br />Price ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Remaining Contractual Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1003px; font-weight: bold;">Balance - December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 142px; text-align: right;">50,000,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.03</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">2.75</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Granted</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Exercised</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Expired</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">Cancelled</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance &#8211; September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">50,000,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.03</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2.00</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Warrants</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">As of September 30, 2018, there was no unamortized warrant expense.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">A summary of the status of the Company&#8217;s stock warrants and changes is set forth below:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Warrants<br />(#)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise<br />Price&#160;($)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Remaining Contractual Life&#160;(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1003px; font-weight: bold;">Balance - December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 142px; text-align: right;">65,000,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.004</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.17</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Granted</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Cancelled</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Expired</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">65,000,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.004</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">Exercised</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance &#8211; September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 6 &#8211; INTANGIBLE ASSETS</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Intangible assets include patents purchased and are recorded based at their acquisition cost. Intangible assets consisted of the following:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2">Weighted<br />average</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2">September&#160;30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2">December&#160;31,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2">amortization<br />period</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(years)</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1003px;">Patents</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 142px; text-align: right;">4,020,000</td> <td style="width: 16px; text-align: left;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">4,000,000</td> <td style="width: 15px; text-align: left;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="width: 15px; text-align: left;">&#160;</td> <td style="width: 141px; text-align: right;">9.8</td> <td style="width: 15px; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Less: net monetization obligations</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(509,811</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(509,811</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Imputed interest</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(376,291</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(376,291</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td>Subtotal</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">3,133,898</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">3,113,898</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1.5pt;">Less: accumulated amortization</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(983,850</td> <td style="text-align: left; padding-bottom: 1.5pt;">)</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(650,560</td> <td style="text-align: left; padding-bottom: 1.5pt;">)</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 4pt;">Net value of intangible assets</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,150,048</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,463,338</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> <td style="text-align: right; padding-bottom: 4pt;">8.2</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Intangible assets are comprised of patents with estimated useful lives. The intangible assets at September 30, 2018 represent: (1) patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years, (2) patents acquired in July 2017 pursuant to an obligation to distribute 50% of net revenues to IV 34/37, against which $25,000 was advanced at closing and provided that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions of 50% of net revenues to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/37; the useful lives of the patents, at the date of acquisition, was 5-6 years, (3) patents (which were fully depreciated at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC &#8220;(IV 62/71&#8221;), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71 against which CXT advanced $10,000 at closing; and (4) patents acquired in January 2018 by Photonic Imaging Solutions Inc. (&#8220;PIS&#8221;) from Intellectual Ventures Assets 64 LLC (&#8220;IV 64&#8221;) pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000, against which PIS advanced $10,000 at closing. The Company amortizes the costs of intangible assets over their estimated useful lives on a straight-line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included as a selling, general and administrative expense in the accompanying consolidated statements of operations.</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company assesses intangible assets for any impairment to the carrying values. As of September 30, 2018, and December 31, 2017, management concluded that there was no impairment to the acquired assets. At September 30, 2018 and December 31, 2017, the net book value of the Company&#8217;s intellectual property was $2,150,048 and $2,463,338, respectively.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Amortization expense for patents comprised $333,290 and $331,275 for the nine months ended September 30, 2018 and the year ended December 31, 2017, respectively. Future amortization of intangible assets is as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Year ended December 31,</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td colspan="2">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1379px; text-align: left;">2018</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">104,430</td> <td style="width: 15px; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">2019</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">417,719</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">2020</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">417,719</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">2021</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">413,658</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1.5pt;">2022 and thereafter</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">796,522</td> <td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 4pt;">Total</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,150,048</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, 15% of the net monetization proceeds from the patents acquired in October 2015 will be paid to the lender, United Wireless. This monetization obligation was recognized as a discount to the loan and is being amortized over the life of the loan using the effective interest method. In addition, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT in July 2017. This obligation was recorded as an expense and is reflected in interest expense during the third quarter of 2017.&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company granted IV 34/37 a security interest in the patents assigned to CXT as security for the payment of the balance of the purchase price. The security interest of IV 34/37 is senior to the security interest of United Wireless in the proceeds derived from such patents.</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The balance of the purchase price of the patents is reflected as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30,<br />2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">December&#160;31,&#160;<br />2017</td> <td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>Current Liabilities:</td> <td>&#160;</td> <td style="text-align: right;" colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2">&#160;</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; text-align: left;">Purchase price of patents, current portion</td> <td style="width: 16px;">&#160;</td> <td style="width: 16px; text-align: left;">&#160;</td> <td style="width: 142px; text-align: right;">100,000</td> <td style="width: 16px; text-align: left;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">100,000</td> <td style="width: 15px; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Unamortized discount</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Non-current liabilities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Purchase price of patents, long term</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">875,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">875,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Unamortized discount</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(123,321</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(175,243</td> <td style="text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Total current and non-current</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">851,679</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">799,757</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Effective interest rate of Amortized over 2-3 years</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9.2-9.6</td> <td style="text-align: left;">%</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Because the non-current minimum payment obligations of $875,000 are due over the next three years, the Company imputed interest of 10% and the interest will be accreted up to the maturity date.</font></p> </div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 7 &#8211; NON-CONTROLLING INTEREST</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The following table reconciles equity attributable to the non-controlling interest related to Quest Packaging Solutions Corporation.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; font-weight: bold;">Balance as of December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">3,219</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt;">Net income attributable to non-controlling interest</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(1,511</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance as of September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1,708</td><td style="text-align: left; padding-bottom: 4pt;"></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p></div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 8 &#8211; RELATED PARTY TRANSACTIONS</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company has at various times entered into transactions with related parties, including officers, directors and major stockholders, pursuant to which, these related parties have provided services, advanced or loaned money, or both, to the Company needed to support its daily operations. The Company discloses all related party transactions.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">See Notes 3 and 6 in connection with transactions with United Wireless. During the three- and nine-months ended September 30, 2018 and 2017, the Company incurred interest expense on the Company&#8217;s 10% notes issued to United Wireless pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017. The interest expense was approximately $108,000 and $310,000 for the three- and nine-months ended September 30, 2018, respectively, and approximately $72,000 and $208,000 for the three- and nine-months ended September 30, 2017, respectively. On each of September 30, 2017 and 2018, accrued interest is added to the principal amount of the note.</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">During the three and nine months ended September 30, 2018 and 2017, the Company contracted with an entity owned by the chief technology officer for the provision of information technology services to the Company. The cost of such services was approximately $205 and $625 for the three and nine months ended September 30, 2018, respectively, and approximately $205 and $850 for the three and nine months ended September 30, 2017, respectively.</font></p> </div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>NOTE 9 &#8211; COMMITMENTS AND CONTINGENCIES</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Employment Agreements</i></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Pursuant to a restated employment agreement, dated November 30, 2014, with the Company&#8217;s president and chief executive officer, the Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days&#8217; notice prior to the expiration of the initial term or any one-year extension. Pursuant to the agreement, the chief executive officer currently receives an annual salary to $300,000. The chief executive officer is entitled to a bonus if the Company meets or exceed performance criteria established by the compensation committee. In August 2016, the Company&#8217;s board of directors approved annual bonus compensation equal to 30% of the amount by which the Company&#8217;s consolidated income before income taxes exceeds $500,000, but, if the Company is subject to the limitation on deductibility of executive compensation pursuant to Section 162(m) of the Internal Revenue Code, the bonus cannot exceed the amount which would be deductible pursuant to Section 162(m). The chief executive officer is also eligible to participate in any executive incentive plans which the Company may adopt.</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;"><i>Inventor Royalties, Contingent Litigation Funding Fees and Contingent Legal Expenses</i></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;"><i>&#160;</i></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">In connection with the investment in certain patents and patent rights, certain of the Company&#8217;s operating subsidiaries executed agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may engage third party funding sources to provide funding for patent licensing and enforcement. The agreements with the third-party funding sources may provide that the funding source receive a portion of any negotiated fees, settlements or judgments. In certain instances, these third-party funding sources are entitled to receive a significant percentage of any proceeds realized until the third-party funder has recouped agreed upon amounts based on formulas set forth in the underlying funding agreement, which may reduce or delay and proceeds due to the Company.&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may retain the services of law firms in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby the law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Depending on the amount of any recovery, it is possible that all the proceeds from a specific settlement may be paid to the funding source and legal counsel.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The economic terms of the inventor agreements, funding agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by the Company&#8217;s operating subsidiaries, if any, including royalty rates, proceeds sharing rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by the operating subsidiaries. Inventor royalties, payments to noncontrolling interests, payments to third party funding providers and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, payments to third party funding sources and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In March 2014, the Company entered into a funding agreement whereby a third party agreed to provide funds to the Company to enable the Company to implement a structured licensing program, including litigation if necessary, for the Mobile Data. Under the funding agreement, the third party receives an interest in the proceeds from the program, and the Company has no other obligation to the third party. In April and June 2014, as part of a structured licensing program for the Mobile Data portfolio, Quest Licensing Corporation brought patent infringement suits in the U.S. District for the District of Delaware against Bloomberg LP et. al., FactSet Research Systems Inc., Interactive Data Corporation, SunGard Data Systems Inc. and The Charles Schwab Corporation et. al. These cases have been consolidated for trial. In June and August 2016, Quest Licensing Corporation entered into a settlement agreement with SunGard Data Systems Inc. and FactSet Research Systems Inc. As of the date of filing the third-party funder has advanced approximately $3,000,000 in litigation fees, costs and expenses. Under the terms of the funding agreement, the third-party funder is entitled to a priority return of funds advanced from any proceeds recovered. The Company&#8217;s management fees and management support services expenses relate to this agreement.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Patent Enforcement and Other Litigation</i></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Certain of the Company&#8217;s operating subsidiaries are engaged in litigation to enforce their patents and patent rights. In connection with these patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against the Company or its operating subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by the Company or its operating subsidiaries, could materially harm the Company&#8217;s operating results and financial position and could result in a default under the Company&#8217;s loans. Since the operating subsidiaries do not have any assets other than the patents, and the Company does not have any available financial resources to pay any judgment which a defendant may obtain against a subsidiary, such a judgement may result in the bankruptcy of the subsidiary and/or the loss of the patents, which are the subsidiaries&#8217; only assets.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">On January 19, 2017, the court in the Mobile Data Portfolio litigation granted the defendants&#8217; motion for summary judgment of non-infringement, which Quest Licensing Corporation has appealed. Following the court&#8217;s decision granting the defendant&#8217;s motion for summary judgment, the defendants moved for an award of attorneys&#8217; fees under Section 285 of the Patent Act, which provides that &#8220;the court in exceptional cases may award reasonable attorney fees to the prevailing party.&#8221; Such a motion, if granted, would result in a judgment against Quest Licensing Corporation, which does not have the financial resources to enable it to pay any judgment which may be rendered against it, and, the defendants may seek to enforce their judgment by seeking to foreclose on the patents owned by the subsidiary or seek to force the subsidiary into bankruptcy and purchase the patents in the bankruptcy proceeding, either of which could result in a default under the Company&#8217;s agreement with United Wireless. The possible amount of any judgment cannot be estimated and the funding source for the litigation will not provide the Company with funds to pay an adverse judgment. On June 29, 2017, the defendants&#8217; motion for attorney fees in the Mobile Data litigation was denied, without prejudice. Defendants may renew their motion thirty days from the decision of the appellate court. On June 8, 2018 the appellate court affirmed the lower court&#8217;s decision. On June 9, 2018 Quest Licensing Corporation filed a petition for rehearing with the appellate court. On July 30, 2018 the appellate court denied Quest Licensing Corporations petition for rehearing. On August 8, 2018, the defendants&#8217; renewed their motion for an award of attorneys&#8217; fees under Section 285 of the Patent Act.</font></p> </div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Principles of consolidation and financial statement presentation</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (&#8220;US GAAP&#8221;) and present the consolidated financial statements of the Company and its wholly-owned and majority owned subsidiaries as of September 30, 2018.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The consolidated financial statements include the accounts and operations of:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1519px; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Patent Research Corporation (&#8220;the Company&#8221;)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Licensing Corporation (NY) (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Licensing Corporation (DE) (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Packaging Solutions Corporation (90% owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Quest Nettech Corporation (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Semcon IP, Inc. (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Mariner IC, Inc. (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">IC Kinetics, Inc. (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">CXT Systems, Inc. (wholly-owned)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0.5in; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Photonic Imaging Solutions Inc. (wholly-owned)</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The operations of Wynn Technologies Inc. are not included in the Company&#8217;s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc. The sole asset of Wynn Technologies Inc. is US Patent No. RE38,137E. Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company accounts for its 65% interest in Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 60% share of income pursuant to the contractual agreement, which provides that Sol Li retains 40% of the income, and are reduced for distributions and its 60% share of losses incurred, respectively, with the restriction whereby the account balances cannot go below zero.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Significant intercompany transaction and balances have been eliminated in consolidation.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Use of Estimates</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Intangible Assets</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Patents include the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims that, based on management&#8217;s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Derivative Financial Instruments</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black Scholes model, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221; to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Fair value of financial instruments</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for information about derivative liabilities.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 1</i>&#160;&#8211; Quoted prices in active markets for identical assets or liabilities.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 2</i>&#160;&#8211; Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><i>Level 3</i>&#160;&#8211; Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Income Tax</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company records revenues on a gross basis, before deduction for income taxes. The Company incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three and nine months ended September 30, 2018 and approximately $170 and approximately $105,000 for the three and nine months ended September 30, 2017.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In connection with the investment in certain patents and patent rights, certain of the Company&#8217;s operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company&#8217;s operating subsidiaries may engage with funding sources that provide financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by the Company&#8217;s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Revenue Recognition</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company recognizes revenue in accordance with ASC Topic 606, &#8220;Revenue from Contracts with Customers&#8221;. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. The Company adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.</font></p></div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Recent Accounting Pronouncements</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company is currently evaluating ASC 842 &#8220;Leases&#8221; for future adoption, which the Company will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. The Company does not believe that this guidance will affect its accounting.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Other than those pronouncements, management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</font></p> </div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><u>Going Concern</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">As shown in the accompanying financial statements, the Company has an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. The Company generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by the Company&#8217;s subsidiaries that own the patents of their rights to the patents, which will further reduce the ability of the Company to generate revenue and the Company may be unable to continue in business. Because of the Company&#8217;s lack of a revenue stream, continuing losses, the working capital deficiency, the uncertainty of future revenue, the Company&#8217;s low stock price and the absence of a trading market in its common stock, the ability of the Company to raise funds in equity market or from lenders is severely impaired. These conditions raise substantial doubt as to the Company&#8217;s ability to continue as a going concern. Although the Company may seek to raise funds and to obtain third party funding for litigation to enforce its intellectual property rights, the availability of such funds is uncertain and the disbursement of any such funds will be controlled by the lender. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> </div> <div> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; font-size-adjust: none; font-stretch: normal;" colspan="2">September&#160;30,</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; font-size-adjust: none; font-stretch: normal;" colspan="2">December&#160;31,</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;" colspan="2">2018</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;" colspan="2">2017</td> <td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Short-term debt:</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 1191px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Loans payable &#8211; third party</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">163,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">163,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Loan payable &#8211; related party</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Gross</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">4,277,351</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">4,027,351</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Accrued Interest</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">395,459</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">85,757</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">Unamortized discount</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(418,866</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(517,182</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Net loans payable &#8211; related party</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">4,253,944</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">3,595,926</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Total short-term debt</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">4,916,944</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">3,758,926</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">Long-term liabilities:</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Purchase price of patents</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> <td style="text-align: right; font-size: 10pt;">&#160;</td> <td style="text-align: left; font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">Gross</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">875,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-size-adjust: none; font-stretch: normal;">875,000</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">Unamortized discount</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(123,321</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size-adjust: none; font-stretch: normal;">(175,243</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-size-adjust: none; font-stretch: normal;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">Net purchase price of patents &#8211; long-term</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">751,679</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">$</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size-adjust: none; font-stretch: normal;">699,757</td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-size-adjust: none; font-stretch: normal;">&#160;</td> </tr> </table> </div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Period Ended&#160;<br />September&#160;30,</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Volatility</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">417 % - 460</font></td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1379px; text-align: left;">Risk-free interest rate</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">1.36</td><td style="width: 15px; text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Expected dividends</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</font></td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Expected term</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right; white-space: nowrap;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">2.00 &#8211; 2.75&#160;years</font></td><td style="text-align: left;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="22">Fair Value Measurements as of</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">September 30, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2017</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-weight: bold;">Assets</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">None</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Total assets</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-weight: bold;">Liabilities</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 439px; text-align: left; padding-bottom: 1.5pt;">Option derivative liability</td><td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">115,000</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">90,000</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 4pt;">Total liabilities</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">115,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">90,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant Unobservable<br />Inputs<br />(Level&#160;3)<br />as of<br />September&#160;30, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; text-align: justify;">Beginning balance</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">90,000</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-bottom: 1.5pt;">Change in fair value</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">25,000</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt;">Ending balance</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">115,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Warrants<br />(#)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise<br />Price&#160;($)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Remaining Contractual Life&#160;(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1003px; font-weight: bold;">Balance - December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 142px; text-align: right;">65,000,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.004</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.17</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Granted</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Cancelled</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Expired</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">65,000,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.004</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">Exercised</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance &#8211; September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Options<br />(#)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise<br />Price ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Remaining Contractual Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1003px; font-weight: bold;">Balance - December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 142px; text-align: right;">50,000,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">0.03</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">2.75</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Granted</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Exercised</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Expired</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">-</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">Cancelled</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance &#8211; September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">50,000,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.03</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2.00</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">Weighted<br />average</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">September&#160;30,</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">December&#160;31,</td><td style="font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold;" colspan="2">amortization<br />period</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(years)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1003px;">Patents</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 142px; text-align: right;">4,020,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">4,000,000</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">&#160;</td><td style="width: 141px; text-align: right;">9.8</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Less: net monetization obligations</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(509,811</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(509,811</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Imputed interest</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(376,291</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(376,291</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Subtotal</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">3,133,898</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">3,113,898</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt;">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(983,850</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(650,560</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="text-align: right; padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt;">Net value of intangible assets</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,150,048</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,463,338</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td><td style="text-align: right; padding-bottom: 4pt;">8.2</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Year ended December 31,</td><td style="padding-bottom: 1.5pt;">&#160;</td><td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; text-align: left;">2018</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">104,430</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">2019</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">417,719</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">2020</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">417,719</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">2021</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">413,658</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt;">2022 and thereafter</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">796,522</td><td style="text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt;">Total</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,150,048</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30,<br />2018</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">December&#160;31,&#160;<br />2017</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>Current Liabilities:</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left;">Purchase price of patents, current portion</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 142px; text-align: right;">100,000</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">$</td><td style="width: 141px; text-align: right;">100,000</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Unamortized discount</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Non-current liabilities:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Purchase price of patents, long term</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">875,000</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">875,000</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Unamortized discount</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(123,321</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(175,243</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Total current and non-current</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">851,679</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">799,757</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Effective interest rate of Amortized over 2-3 years</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">9.2-9.6</td><td style="text-align: left;">%</td></tr></table> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; font-weight: bold;">Balance as of December 31, 2017</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">3,219</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt;">Net income attributable to non-controlling interest</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(1,511</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-weight: bold;">Balance as of September 30, 2018</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1,708</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000. 250000 0.65 0.90 0.60 0.40 0.60 5097000 170 105000 0 1040000 4027351 4277351 85757 395459 517182 418866 3595926 4253944 875000 875000 175243 175243 123321 123321 0.10 4277351 25000 On June 12, 2017, the Company entered into a standstill agreement with United Wireless pursuant to which the Company agreed (i) to increase its authorized common stock to 10,000,000,000 shares, (ii) to file by June 30, 2017, a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement, (iii) if the existing warrant held by the Company's chief executive officer is not exercised prior to its expiration date, any re-issuance will not have an exercise price less than the current exercise price and the existing warrants will not be amended to lower the exercise price, and (iv) United Wireless no longer has any obligation to purchase any note pursuant to the securities purchase agreement other than the $1,000,000 note related to the final payment to Intellectual Ventures which was made in November 2017, except in connection with the potential acquisition by the Company of patent rights which triggered a $25,000 working capital loan in connection with the acquisition and the Company can require United Wireless to make $125,000 working capital loans to the Company, at the Company's sole discretion, on December 31, 2017, March 31, 2018 and June 30, 2018 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 and, in such event, United Wireless would have a 7.5% net proceeds percentage interest in the net proceeds from such patent. 0.10 2020-09-30 0.10 25000 25000 0.075 0.50 25000 100000 375000 975000 4.60 4.17 0.0136 P2Y9M0D P2Y0M0D 90000 115000 90000 115000 90000 115000 25000 90000 115000 65000000 50000000 50000000 65000000 0.004 0.03 0.03 0.004 P0Y2M1D P2Y9M0D P0Y P2Y0M0D 4000000 4020000 509811 509811 376291 376291 3113898 3133898 650560 983850 P8Y2M12D P9Y9M18D 104430 417719 417719 413658 796522 2150048 875000 875000 799757 851679 0.096 0.092 (1) patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years, (2) patents acquired in July 2017 pursuant to an obligation to distribute 50% of net revenues to IV 34/37, against which $25,000 was advanced at closing and provided that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions of 50% of net revenues to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/37; the useful lives of the patents, at the date of acquisition, was 5-6 years, (3) patents (which were fully depreciated at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC "(IV 62/71"), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71 against which CXT advanced $10,000 at closing; and (4) patents acquired in January 2018 by Photonic Imaging Solutions Inc. ("PIS") from Intellectual Ventures Assets 64 LLC ("IV 64") pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000, against which PIS advanced $10,000 at closing. P10Y P6Y 2463338 2150048 331275 333290 0.15 0.075 875000 Due over the next three years. P3Y P2Y 205 850 205 625 72000 208000 108000 310000 The Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days' notice prior to the expiration of the initial term or any one-year extension. 300000 The Company's board of directors approved annual bonus compensation equal to 30% of the amount by which the Company's consolidated income before income taxes exceeds $500,000. 3000000 3758926 4916944 EX-101.SCH 5 qprc-20180930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Unaudited Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Unaudited Consolidated Statement of Operations link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Unaudited Consolidated Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Unaudited Consolidated Statement of Cash Flows (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Short-Term Debt and Long Term Liabilities link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Derivative Liabilities link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Non-Controlling Interest link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Short-Term Debt and Long Term Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Non-Controlling Interest (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Short-Term Debt and Long Term Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Short-Term Debt and Long Term Liabilities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Derivative Liabilities (Details 1) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Derivative Liabilities (Details 2) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Derivative Liabilities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stockholders' Equity (Details ) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Intangible Assets (Details 1) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Intangible Assets (Details 2) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Intangible Assets (Details Textual) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Non-Controlling Interest (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 qprc-20180930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 qprc-20180930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 qprc-20180930_lab.xml XBRL LABEL FILE EX-101.PRE 9 qprc-20180930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 14, 2018
Document and Entity Information [Abstract]    
Entity Registrant Name QUEST PATENT RESEARCH CORP  
Entity Central Index Key 0000824416  
Trading Symbol QPRC  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2018  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   383,038,334
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 37,589 $ 165,546
Accounts receivable 6,050 2,846
Other current assets 1,989 2,522
Total current assets 45,628 170,914
Patents, net of accumulated amortization of $983,850 and $650,560, respectively 2,150,048 2,463,338
Total assets 2,195,676 2,634,252
Current liabilities:    
Accounts payable and accrued liabilities 233,623 147,356
Loans payable - third party 163,000 163,000
Purchase price of patents, current portion 100,000 100,000
Loan payable - related party, net of unamortized discount and debt issuance costs of $418,866 and $517,182, respectively 3,858,485 3,510,169
Accrued interest - loans payable related party 395,459 85,757
Accrued interest - loans payable third party 277,439 265,214
Derivative liability 115,000 90,000
Total current liabilities 5,143,006 4,361,496
Non-current liabilities    
Purchase price of patents, current portion, net of unamortized discount of $123,321 and $175,243, respectively 751,679 699,757
Total liabilities 5,894,685 5,061,253
Stockholders' deficit:    
Preferred stock - par value $.00003 per share - authorized 10,000,000 Shares - no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 shares at September 30, 2018 and December 31, 2017, shares issued and outstanding 383,038,334 and 383,038,334, at September 30, 2018 and December 31, 2017 11,491 11,491
Additional paid-in capital 14,107,782 14,107,782
Accumulated deficit (17,819,990) (16,549,493)
Total Quest Patent Research Corporation deficit (3,700,717) (2,430,220)
Non-controlling interest in subsidiary 1,708 3,219
Total stockholders' deficit (3,699,009) (2,427,001)
Total liabilities and stockholders' deficit $ 2,195,676 $ 2,634,252
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Balance Sheets (Parenthetical) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Consolidated Balance Sheets [Abstract]    
Patents, net of accumulated amortization $ 983,850 $ 650,560
Loan payable - related party unamortized discount, current 418,866 517,182
Purchase price of patents unamortized discount $ 123,321 $ 175,243
Preferred stock, par value $ 0.00003 $ 0.00003
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value $ 0.00003 $ 0.00003
Common stock, shares authorized 10,000,000,000 10,000,000,000
Common stock, shares issued 383,038,334 383,038,334
Common stock, shares outstanding 383,038,334 383,038,334
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Statement of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues        
Licensed Sales $ 6,050 $ 2,846 $ 20,003 $ 8,509
Patent licensing fees 575,000 7,049,000 1,196,250
Management fees 24,302
Total revenue 6,050 577,846 7,069,003 1,229,061
Cost of revenue:        
Cost of sales 1,095 377 3,689 1,449
Litigation and licensing expenses 32,460 282,621 6,041,560 807,614
Management support services 396 6,609 25,068
Selling, general and administrative expenses 210,177 197,407 751,863 610,278
Total operating expenses 243,732 480,801 6,803,721 1,444,409
Income /(loss) from operations (237,682) 97,045 265,282 (215,348)
Other Income and (expenses)        
Gain (loss) on derivative (40,000) (40,000) (25,000) 40,000
Interest expense (165,382) (194,833) (472,165) (426,860)
Total Other Income and (expenses) (205,381) (234,833) (497,164) (386,860)
Net (loss) before income tax (443,063) (137,788) (231,882) (602,208)
Income tax (170) (1,040,125) (105,410)
Net loss (443,063) (137,958) (1,272,008) (707,618)
Net income (loss) attributable to non-controlling interest in subsidiaries 485 21 1,511 (1,190)
Net loss attributable to Quest Patent Research Corporation $ (442,579) $ (137,937) $ (1,270,497) $ (708,808)
Loss per share - basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average shares outstanding - basic and diluted 383,038,334 313,038,334 383,038,334 313,038,334
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Statement of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net loss $ (1,272,008) $ (707,618)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discounts 150,238 147,128
Loss on monetization agreement 59,811
Gain on derivative 25,000 (40,000)
Depreciation and amortization 333,290 226,846
Changes in operating assets and liabilities    
Accounts receivable (3,204) 38,358
Accrued interest - loans payable related party 309,702 195,470
Accrued interest - loans payable third party 12,225 12,225
Other current assets 533 533
Accounts payable and accrued expenses 86,267 1,464
Net cash used in operating activities (357,957) (65,783)
Cash flows from investing activities    
Purchase of patents (20,000)
Net cash provided by investing activities (20,000)
Cash flows from financing activities    
Proceeds from loans-related party 250,000
Net cash provided by financing activities 250,000
Net decrease in cash and cash equivalents (127,957) (65,783)
Cash and cash equivalents at beginning of year 165,546 208,324
Cash and cash equivalents at end of year 37,589 142,541
Cash paid during the year for:    
Income taxes including foreign taxing authorities withheld taxes of $1,039,900 and $101,250 during the period ended September 30, 2018, and 2017 respectively. 1,040,125 105,410
Interest
Non-cash investing and financing activity:    
Loan proceeds paid directly from lender to seller of patents 25,000
Accounts payable for purchase of patent, net of imputed interest of $202,522 $ 772,478
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Statement of Cash Flows (Parenthetical) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Statement of Cash Flows [Abstract]    
Foreign taxing authorities withheld taxes $ 1,039,900 $ 101,250
Net of imputed interest $ 202,522
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Description of Business and Basis of Presentation
9 Months Ended
Sep. 30, 2018
Description of Business and Basis of Presentation [Abstract]  
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1 – DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

The Company is a Delaware corporation, incorporated on July 17, 1987 and has been engaged in the intellectual property monetization business since 2008.

 

As used herein, the “Company” refers to Quest Patent Research Corporation and its wholly and majority-owned and controlled operating subsidiaries unless the context indicates otherwise. All intellectual property acquisition, development, licensing and enforcement activities are conducted by the Company’s wholly and majority-owned and controlled operating subsidiaries.

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the US (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these interim financial statements do not include all of the information and notes required by GAAP for complete financial statements. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s consolidated financial position have been included. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2017. Operating results for the interim periods presented herein are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. Reclassifications from prior periods have been made to conform with the current year presentation.

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2018
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of consolidation and financial statement presentation

 

The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and present the consolidated financial statements of the Company and its wholly-owned and majority owned subsidiaries as of September 30, 2018.

 

The consolidated financial statements include the accounts and operations of:

 

Quest Patent Research Corporation (“the Company”)
Quest Licensing Corporation (NY) (wholly-owned)
Quest Licensing Corporation (DE) (wholly-owned)
Quest Packaging Solutions Corporation (90% owned)
Quest Nettech Corporation (wholly-owned)
Semcon IP, Inc. (wholly-owned)
Mariner IC, Inc. (wholly-owned)
IC Kinetics, Inc. (wholly-owned)
CXT Systems, Inc. (wholly-owned)
Photonic Imaging Solutions Inc. (wholly-owned)

 

The operations of Wynn Technologies Inc. are not included in the Company’s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc. The sole asset of Wynn Technologies Inc. is US Patent No. RE38,137E. Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.

 

The Company accounts for its 65% interest in Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 60% share of income pursuant to the contractual agreement, which provides that Sol Li retains 40% of the income, and are reduced for distributions and its 60% share of losses incurred, respectively, with the restriction whereby the account balances cannot go below zero.

 

Significant intercompany transaction and balances have been eliminated in consolidation.

 

Use of Estimates

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Intangible Assets

 

Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent.

 

Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims that, based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

 

Derivative Financial Instruments

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black Scholes model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.

 

Fair value of financial instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for information about derivative liabilities.

 

The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. 

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.

 

Income Tax

 

The Company records revenues on a gross basis, before deduction for income taxes. The Company incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three and nine months ended September 30, 2018 and approximately $170 and approximately $105,000 for the three and nine months ended September 30, 2017.

 

Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses

 

In connection with the investment in certain patents and patent rights, certain of the Company’s operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

The Company’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded.

 

The Company’s operating subsidiaries may engage with funding sources that provide financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.

 

The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by the Company’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. The Company adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.

 

Recent Accounting Pronouncements

 

The Company is currently evaluating ASC 842 “Leases” for future adoption, which the Company will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. The Company does not believe that this guidance will affect its accounting.

 

Other than those pronouncements, management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on the Company’s financial statements.

 

Going Concern

 

As shown in the accompanying financial statements, the Company has an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. The Company generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by the Company’s subsidiaries that own the patents of their rights to the patents, which will further reduce the ability of the Company to generate revenue and the Company may be unable to continue in business. Because of the Company’s lack of a revenue stream, continuing losses, the working capital deficiency, the uncertainty of future revenue, the Company’s low stock price and the absence of a trading market in its common stock, the ability of the Company to raise funds in equity market or from lenders is severely impaired. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Although the Company may seek to raise funds and to obtain third party funding for litigation to enforce its intellectual property rights, the availability of such funds is uncertain and the disbursement of any such funds will be controlled by the lender. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Short-Term Debt and Long Term Liabilities
9 Months Ended
Sep. 30, 2018
Short-Term Debt and Long Term Liabilities [Abstract]  
SHORT-TERM DEBT AND LONG TERM LIABILITIES

NOTE 3 – SHORT-TERM DEBT AND LONG TERM LIABILITIES

 

The following table shows the Company’s short-term and long-term debt at September 30, 2018 and December 31, 2017.

 

    September 30,     December 31,  
    2018     2017  
Short-term debt:            
Loans payable – third party   $ 163,000     $ 163,000  
                 
Loan payable – related party                
Gross     4,277,351       4,027,351  
Accrued Interest     395,459       85,757  
Unamortized discount     (418,866 )     (517,182 )
Net loans payable – related party   $ 4,253,944     $ 3,595,926  
Total short-term debt   $ 4,916,944     $ 3,758,926  
Long-term liabilities:                
Purchase price of patents                
Gross     875,000       875,000  
Unamortized discount     (123,321 )     (175,243 )
Net purchase price of patents – long-term   $ 751,679     $ 699,757  

 

The loan payable – third party is a demand loan made by former officers and directors, who are unrelated third parties at September 30, 2018 and December 31, 2017, in the amount of $163,000. The loans are payable on demand plus accrued interest at 10% per annum. These third parties are also shareholders, but their stockholdings are not significant. 

 

The loan payable – related party at September 30, 2018 represents the principal amount of the Company’s 10% note to United Wireless Holdings, Inc. (“United Wireless”) in the amount of $4,277,351 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. United Wireless was not a related party at the time of the loan. On March 16, 2017, the Company received a letter from counsel to United Wireless claiming that the Company is in violation of the requirements of the registration rights agreement dated October 22, 2015 on the grounds that the Company did not update the registration statement in November 2016. The Company disputed the claim that it was in breach of the registration rights agreement. On June 12, 2017, the Company entered into a standstill agreement with United Wireless pursuant to which the Company agreed (i) to increase its authorized common stock to 10,000,000,000 shares, (ii) to file by June 30, 2017, a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement, (iii) if the existing warrant held by the Company’s chief executive officer is not exercised prior to its expiration date, any re-issuance will not have an exercise price less than the current exercise price and the existing warrants will not be amended to lower the exercise price, and (iv) United Wireless no longer has any obligation to purchase any note pursuant to the securities purchase agreement other than the $1,000,000 note related to the final payment to Intellectual Ventures which was made in November 2017, except in connection with the potential acquisition by the Company of patent rights which triggered a $25,000 working capital loan in connection with the acquisition and the Company can require United Wireless to make $125,000 working capital loans to the Company, at the Company’s sole discretion, on December 31, 2017, March 31, 2018 and June 30, 2018 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 and, in such event, United Wireless would have a 7.5% net proceeds percentage interest in the net proceeds from such patent. On June 15, 2017, the Company amended its certificate of incorporation to increase its authorized common stock to 10,000,000,000 shares. On June 30, 2017, the Company filed a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement. The registration statement was declared effective on July 6, 2017. The Company issued to United Wireless a 10% promissory note due September 30, 2020 in the principal amount of $25,000 pursuant to the standstill agreement, for which the Company received $25,000, which was used to make the $25,000 advance to Intellectual Ventures Assets 34 LLC and Intellectual Ventures Assets 37 LLC (“IV 34/37”) as part of acquisition of intellectual property from IV 34/37. In connection with the loan, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT from IV 34/37. This obligation was recorded as an expense related to obtaining the standstill agreement and is reflected in interest expenses. CXT’s obligations under the monetization proceeds agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio. The security interest in the proceeds from the CXT Portfolio is junior to the security interest held by IV 34/37 in the CXT Portfolio and proceeds thereof. The notes payable to United Wireless have been classified as current liabilities as of September 30, 2018. Because of its right to elect a director of the Company under the securities purchase agreement, United Wireless is treated as a related party. Prior to the securities purchase agreement with United Wireless, the Company had no relationship with United Wireless.

 

Long-term liabilities

 

The purchase price of patents at September 30, 2018 represents the non-current portion of minimum payments due under the agreement between CXT Systems, Inc. (“CXT”), a wholly-owned subsidiary, and IV 34/37 pursuant to which at closing CXT acquired by assignment all right, title, and interest in a portfolio of fourteen United States patents, five foreign patents and six related applications (the “CXT Portfolio”). Under the agreement, CXT will distribute 50% of net recoveries, as defined, to IV 34/37. CXT advanced $25,000 to IV 34/37 at closing, and agreed that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/36. No affiliate of CXT has guaranteed the minimum payments. CXT’s obligations under the agreement are secured by a security interest in the proceeds (from litigation or otherwise) from the CXT Portfolio.

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities
9 Months Ended
Sep. 30, 2018
Derivative Liabilities [Abstract]  
DERIVATIVE LIABILITIES

NOTE 4 – DERIVATIVE LIABILITIES

 

Because there is not a fixed conversion price, the ability of the Company to remain compliant with the requirement under the United Wireless notes that the Company have sufficient authorized common stock in the event that the notes become convertible is outside of the control of the Company. There is no limit on the number of shares issuable under the note, and absent an increase in the stock price or an increase in authorized shares, it is possible the Company will not have enough authorized shares to satisfy the exercise of outstanding non-employee options and warrants. Thus, the Company determined the options and warrants qualify as derivative liabilities under ASC Topic 815. On January 22, 2016, the Company reclassified all non-employee warrants and options as derivative liabilities and revalued them at their fair values at each balance sheet date. Any change in fair value was recorded as other income (expense) for each reporting period at each balance sheet date. 

 

As of September 30, 2018, and December 31, 2017, the aggregate fair value of the outstanding derivative liability was approximately $115,000 and $90,000, respectively.

 

The Company estimated the fair value of the derivative liability using the Black-Scholes option pricing model using the following key assumptions during the period ended September 30, 2018:

 

    Period Ended 
September 30,
 
    2018  
Volatility     417 % - 460 %
Risk-free interest rate     1.36 %
Expected dividends     - %
Expected term     2.00 – 2.75 years  

 

The following schedule summarizes the valuation of financial instruments at fair value in the balance sheets as of September 30, 2018 and December 31, 2017:

 

    Fair Value Measurements as of  
    September 30, 2018     December 31, 2017  
    Level 1     Level 2     Level 3     Level 1     Level 2     Level 3  
Assets                                    
None     -       -       -       -       -       -  
Total assets     -       -       -       -       -       -  
Liabilities                                                
Option derivative liability     -       -       115,000       -       -       90,000  
Total liabilities   $ -     $ -     $ 115,000     $ -     $ -     $ 90,000  

 

The following table sets forth a reconciliation of changes in the fair value of derivative liabilities classified as Level 3 in the fair value hierarchy:

 

    Significant Unobservable
Inputs
(Level 3)
as of
September 30, 2018
 
Beginning balance   $ 90,000  
Change in fair value     25,000  
Ending balance   $ 115,000  
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity
9 Months Ended
Sep. 30, 2018
Stockholders' Equity [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

 

Issuance of Common Stock and Options

 

There was no stock-based compensation expense for the nine months ended September 30, 2018 or 2017.

 

As of September 30, 2018, there was no unamortized option expense associated with compensatory options. 

 

A summary of the status of the Company’s stock options and changes is set forth below:

 

  Number of Options
(#)
  Weighted Average Exercise
Price ($)
  Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017  50,000,000   0.03   2.75 
Granted  -   -   - 
Exercised  -   -   - 
Expired  -   -   - 
Cancelled  -   -   - 
Balance – September 30, 2018  50,000,000   0.03   2.00 

 

Warrants

 

As of September 30, 2018, there was no unamortized warrant expense.

 

A summary of the status of the Company’s stock warrants and changes is set forth below:

 

  Number of Warrants
(#)
  Weighted Average Exercise
Price ($)
  Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017  65,000,000   0.004   0.17 
Granted  -   -   - 
Cancelled  -   -   - 
Expired  65,000,000   0.004   - 
Exercised  -   -   - 
Balance – September 30, 2018  -   -   - 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets
9 Months Ended
Sep. 30, 2018
Intangible Assets [Abstract]  
INTANGIBLE ASSETS

NOTE 6 – INTANGIBLE ASSETS

 

Intangible assets include patents purchased and are recorded based at their acquisition cost. Intangible assets consisted of the following:

 

                Weighted
average
 
    September 30,     December 31,     amortization
period
 
    2018     2017     (years)  
Patents   $ 4,020,000     $ 4,000,000       9.8  
Less: net monetization obligations     (509,811 )     (509,811 )        
Imputed interest     (376,291 )     (376,291 )        
Subtotal     3,133,898       3,113,898          
Less: accumulated amortization     (983,850 )     (650,560 )        
Net value of intangible assets   $ 2,150,048     $ 2,463,338       8.2  

 

Intangible assets are comprised of patents with estimated useful lives. The intangible assets at September 30, 2018 represent: (1) patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years, (2) patents acquired in July 2017 pursuant to an obligation to distribute 50% of net revenues to IV 34/37, against which $25,000 was advanced at closing and provided that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions of 50% of net revenues to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/37; the useful lives of the patents, at the date of acquisition, was 5-6 years, (3) patents (which were fully depreciated at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC “(IV 62/71”), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71 against which CXT advanced $10,000 at closing; and (4) patents acquired in January 2018 by Photonic Imaging Solutions Inc. (“PIS”) from Intellectual Ventures Assets 64 LLC (“IV 64”) pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000, against which PIS advanced $10,000 at closing. The Company amortizes the costs of intangible assets over their estimated useful lives on a straight-line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included as a selling, general and administrative expense in the accompanying consolidated statements of operations.

 

The Company assesses intangible assets for any impairment to the carrying values. As of September 30, 2018, and December 31, 2017, management concluded that there was no impairment to the acquired assets. At September 30, 2018 and December 31, 2017, the net book value of the Company’s intellectual property was $2,150,048 and $2,463,338, respectively.

 

Amortization expense for patents comprised $333,290 and $331,275 for the nine months ended September 30, 2018 and the year ended December 31, 2017, respectively. Future amortization of intangible assets is as follows:

 

Year ended December 31,      
2018   $ 104,430  
2019     417,719  
2020     417,719  
2021     413,658  
2022 and thereafter     796,522  
Total   $ 2,150,048  

 

Pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, 15% of the net monetization proceeds from the patents acquired in October 2015 will be paid to the lender, United Wireless. This monetization obligation was recognized as a discount to the loan and is being amortized over the life of the loan using the effective interest method. In addition, the Company entered into a monetization agreement with United Wireless pursuant to which the Company agreed to pay United Wireless 7.5% of the net monetization proceeds from the patents acquired by CXT in July 2017. This obligation was recorded as an expense and is reflected in interest expense during the third quarter of 2017. 

 

The Company granted IV 34/37 a security interest in the patents assigned to CXT as security for the payment of the balance of the purchase price. The security interest of IV 34/37 is senior to the security interest of United Wireless in the proceeds derived from such patents.

 

The balance of the purchase price of the patents is reflected as follows:

 

    September 30,
2018
    December 31, 
2017
 
Current Liabilities:            
Purchase price of patents, current portion     100,000     $ 100,000  
Unamortized discount                
Non-current liabilities:                
Purchase price of patents, long term     875,000     $ 875,000  
Unamortized discount     (123,321 )     (175,243 )
Total current and non-current     851,679       799,757  
Effective interest rate of Amortized over 2-3 years             9.2-9.6 %

 

Because the non-current minimum payment obligations of $875,000 are due over the next three years, the Company imputed interest of 10% and the interest will be accreted up to the maturity date.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-Controlling Interest
9 Months Ended
Sep. 30, 2018
Non-Controlling Interest [Abstract]  
NON-CONTROLLING INTEREST

NOTE 7 – NON-CONTROLLING INTEREST

 

The following table reconciles equity attributable to the non-controlling interest related to Quest Packaging Solutions Corporation.

 

Balance as of December 31, 2017 $3,219 
Net income attributable to non-controlling interest $(1,511)
Balance as of September 30, 2018 $1,708

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 8 – RELATED PARTY TRANSACTIONS

 

The Company has at various times entered into transactions with related parties, including officers, directors and major stockholders, pursuant to which, these related parties have provided services, advanced or loaned money, or both, to the Company needed to support its daily operations. The Company discloses all related party transactions.

 

See Notes 3 and 6 in connection with transactions with United Wireless. During the three- and nine-months ended September 30, 2018 and 2017, the Company incurred interest expense on the Company’s 10% notes issued to United Wireless pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. The interest expense was approximately $108,000 and $310,000 for the three- and nine-months ended September 30, 2018, respectively, and approximately $72,000 and $208,000 for the three- and nine-months ended September 30, 2017, respectively. On each of September 30, 2017 and 2018, accrued interest is added to the principal amount of the note.

 

During the three and nine months ended September 30, 2018 and 2017, the Company contracted with an entity owned by the chief technology officer for the provision of information technology services to the Company. The cost of such services was approximately $205 and $625 for the three and nine months ended September 30, 2018, respectively, and approximately $205 and $850 for the three and nine months ended September 30, 2017, respectively.

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
9 Months Ended
Sep. 30, 2018
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

Employment Agreements

 

Pursuant to a restated employment agreement, dated November 30, 2014, with the Company’s president and chief executive officer, the Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days’ notice prior to the expiration of the initial term or any one-year extension. Pursuant to the agreement, the chief executive officer currently receives an annual salary to $300,000. The chief executive officer is entitled to a bonus if the Company meets or exceed performance criteria established by the compensation committee. In August 2016, the Company’s board of directors approved annual bonus compensation equal to 30% of the amount by which the Company’s consolidated income before income taxes exceeds $500,000, but, if the Company is subject to the limitation on deductibility of executive compensation pursuant to Section 162(m) of the Internal Revenue Code, the bonus cannot exceed the amount which would be deductible pursuant to Section 162(m). The chief executive officer is also eligible to participate in any executive incentive plans which the Company may adopt.

 

Inventor Royalties, Contingent Litigation Funding Fees and Contingent Legal Expenses

 

In connection with the investment in certain patents and patent rights, certain of the Company’s operating subsidiaries executed agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

The Company’s operating subsidiaries may engage third party funding sources to provide funding for patent licensing and enforcement. The agreements with the third-party funding sources may provide that the funding source receive a portion of any negotiated fees, settlements or judgments. In certain instances, these third-party funding sources are entitled to receive a significant percentage of any proceeds realized until the third-party funder has recouped agreed upon amounts based on formulas set forth in the underlying funding agreement, which may reduce or delay and proceeds due to the Company. 

 

The Company’s operating subsidiaries may retain the services of law firms in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby the law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

 

Depending on the amount of any recovery, it is possible that all the proceeds from a specific settlement may be paid to the funding source and legal counsel.

 

The economic terms of the inventor agreements, funding agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by the Company’s operating subsidiaries, if any, including royalty rates, proceeds sharing rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by the operating subsidiaries. Inventor royalties, payments to noncontrolling interests, payments to third party funding providers and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, payments to third party funding sources and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

 

In March 2014, the Company entered into a funding agreement whereby a third party agreed to provide funds to the Company to enable the Company to implement a structured licensing program, including litigation if necessary, for the Mobile Data. Under the funding agreement, the third party receives an interest in the proceeds from the program, and the Company has no other obligation to the third party. In April and June 2014, as part of a structured licensing program for the Mobile Data portfolio, Quest Licensing Corporation brought patent infringement suits in the U.S. District for the District of Delaware against Bloomberg LP et. al., FactSet Research Systems Inc., Interactive Data Corporation, SunGard Data Systems Inc. and The Charles Schwab Corporation et. al. These cases have been consolidated for trial. In June and August 2016, Quest Licensing Corporation entered into a settlement agreement with SunGard Data Systems Inc. and FactSet Research Systems Inc. As of the date of filing the third-party funder has advanced approximately $3,000,000 in litigation fees, costs and expenses. Under the terms of the funding agreement, the third-party funder is entitled to a priority return of funds advanced from any proceeds recovered. The Company’s management fees and management support services expenses relate to this agreement.

 

Patent Enforcement and Other Litigation

 

Certain of the Company’s operating subsidiaries are engaged in litigation to enforce their patents and patent rights. In connection with these patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against the Company or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by the Company or its operating subsidiaries, could materially harm the Company’s operating results and financial position and could result in a default under the Company’s loans. Since the operating subsidiaries do not have any assets other than the patents, and the Company does not have any available financial resources to pay any judgment which a defendant may obtain against a subsidiary, such a judgement may result in the bankruptcy of the subsidiary and/or the loss of the patents, which are the subsidiaries’ only assets.

 

On January 19, 2017, the court in the Mobile Data Portfolio litigation granted the defendants’ motion for summary judgment of non-infringement, which Quest Licensing Corporation has appealed. Following the court’s decision granting the defendant’s motion for summary judgment, the defendants moved for an award of attorneys’ fees under Section 285 of the Patent Act, which provides that “the court in exceptional cases may award reasonable attorney fees to the prevailing party.” Such a motion, if granted, would result in a judgment against Quest Licensing Corporation, which does not have the financial resources to enable it to pay any judgment which may be rendered against it, and, the defendants may seek to enforce their judgment by seeking to foreclose on the patents owned by the subsidiary or seek to force the subsidiary into bankruptcy and purchase the patents in the bankruptcy proceeding, either of which could result in a default under the Company’s agreement with United Wireless. The possible amount of any judgment cannot be estimated and the funding source for the litigation will not provide the Company with funds to pay an adverse judgment. On June 29, 2017, the defendants’ motion for attorney fees in the Mobile Data litigation was denied, without prejudice. Defendants may renew their motion thirty days from the decision of the appellate court. On June 8, 2018 the appellate court affirmed the lower court’s decision. On June 9, 2018 Quest Licensing Corporation filed a petition for rehearing with the appellate court. On July 30, 2018 the appellate court denied Quest Licensing Corporations petition for rehearing. On August 8, 2018, the defendants’ renewed their motion for an award of attorneys’ fees under Section 285 of the Patent Act.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2018
Summary of Significant Accounting Policies [Abstract]  
Principles of consolidation and financial statement presentation

Principles of consolidation and financial statement presentation

 

The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and present the consolidated financial statements of the Company and its wholly-owned and majority owned subsidiaries as of September 30, 2018.

 

The consolidated financial statements include the accounts and operations of:

 

Quest Patent Research Corporation (“the Company”)
Quest Licensing Corporation (NY) (wholly-owned)
Quest Licensing Corporation (DE) (wholly-owned)
Quest Packaging Solutions Corporation (90% owned)
Quest Nettech Corporation (wholly-owned)
Semcon IP, Inc. (wholly-owned)
Mariner IC, Inc. (wholly-owned)
IC Kinetics, Inc. (wholly-owned)
CXT Systems, Inc. (wholly-owned)
Photonic Imaging Solutions Inc. (wholly-owned)

 

The operations of Wynn Technologies Inc. are not included in the Company’s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc. The sole asset of Wynn Technologies Inc. is US Patent No. RE38,137E. Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.

 

The Company accounts for its 65% interest in Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 60% share of income pursuant to the contractual agreement, which provides that Sol Li retains 40% of the income, and are reduced for distributions and its 60% share of losses incurred, respectively, with the restriction whereby the account balances cannot go below zero.

 

Significant intercompany transaction and balances have been eliminated in consolidation.

Use of Estimates

Use of Estimates

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.

Intangible Assets

Intangible Assets

 

Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent.

 

Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims that, based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Derivative Financial Instruments

Derivative Financial Instruments

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black Scholes model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.

Fair value of financial instruments

Fair value of financial instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for information about derivative liabilities.

 

The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. 

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.

Income Tax

Income Tax

 

The Company records revenues on a gross basis, before deduction for income taxes. The Company incurred foreign income tax expenses of approximately $0 and approximately $1,040,000 for the three and nine months ended September 30, 2018 and approximately $170 and approximately $105,000 for the three and nine months ended September 30, 2017.

Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses

Inventor/Former Owner Royalties and Contingent Legal/Litigation Finance Expenses

 

In connection with the investment in certain patents and patent rights, certain of the Company’s operating subsidiaries may execute related agreements which grant to the inventors and/or former owners of the respective patents or patent rights, the right to receive a percentage of future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

 

The Company’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid a percentage of any negotiated fees, settlements or judgments awarded.

 

The Company’s operating subsidiaries may engage with funding sources that provide financing for patent licensing and enforcement. These litigation finance firms may be engaged on a non-recourse basis whereby such litigation finance firms are paid a percentage of any negotiated fees, settlements or judgments awarded in exchange for providing funding for legal fees and out of pocket expenses incurred as a result of the licensing and enforcement activities.

 

The economic terms of the inventor agreements, operating agreements, contingent legal fee arrangements and litigation financing agreements associated with the patent portfolios owned or controlled by the Company’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor/former owner royalties, payments to non-controlling interests, contingent legal fees expenses and litigation finance expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor/former owner royalties, contingent legal fees expenses and litigation finance expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms. The Company adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method, with no impact on the consolidated financial position or results of operations.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company is currently evaluating ASC 842 “Leases” for future adoption, which the Company will adopt on January 1, 2019. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases and is consistent with the principles of revenue recognition in Topic 606. The Company does not believe that this guidance will affect its accounting.

 

Other than those pronouncements, management does not believe that there are any other recently issued, but not effective, accounting standards which, if currently adopted, would have a material effect on the Company’s financial statements.

Going Concern

Going Concern

 

As shown in the accompanying financial statements, the Company has an accumulated deficit of approximately $17,820,000 and negative working capital of approximately $5,097,000 as of September 30, 2018. The Company generated nominal revenue in the quarter ended September 30, 2018. The short-term debt at September 30, 2018 includes $4,253,944 of principal and interest due to United Wireless, which is secured by a security interest in our patents as described in Note 3. Our inability to pay these notes when due could result in a default in our loan from United Wireless. If United Wireless seeks to foreclose on the patent rights which secure the debt, it may result in the loss by the Company’s subsidiaries that own the patents of their rights to the patents, which will further reduce the ability of the Company to generate revenue and the Company may be unable to continue in business. Because of the Company’s lack of a revenue stream, continuing losses, the working capital deficiency, the uncertainty of future revenue, the Company’s low stock price and the absence of a trading market in its common stock, the ability of the Company to raise funds in equity market or from lenders is severely impaired. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Although the Company may seek to raise funds and to obtain third party funding for litigation to enforce its intellectual property rights, the availability of such funds is uncertain and the disbursement of any such funds will be controlled by the lender. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Short-Term Debt and Long Term Liabilities (Tables)
9 Months Ended
Sep. 30, 2018
Short-Term Debt and Long Term Liabilities [Abstract]  
Schedule of short-term and long-term debt
    September 30,     December 31,  
    2018     2017  
Short-term debt:            
Loans payable – third party   $ 163,000     $ 163,000  
                 
Loan payable – related party                
Gross     4,277,351       4,027,351  
Accrued Interest     395,459       85,757  
Unamortized discount     (418,866 )     (517,182 )
Net loans payable – related party   $ 4,253,944     $ 3,595,926  
Total short-term debt   $ 4,916,944     $ 3,758,926  
Long-term liabilities:                
Purchase price of patents                
Gross     875,000       875,000  
Unamortized discount     (123,321 )     (175,243 )
Net purchase price of patents – long-term   $ 751,679     $ 699,757  
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities (Tables)
9 Months Ended
Sep. 30, 2018
Derivative Liabilities [Abstract]  
Schedule of fair value of derivative liability using black-scholes option pricing model
  Period Ended 
September 30,
 
  2018 
Volatility  417 % - 460%
Risk-free interest rate  1.36%
Expected dividends  -%
Expected term  2.00 – 2.75 years 
Schedule of valuation of financial instruments
  Fair Value Measurements as of 
  September 30, 2018  December 31, 2017 
  Level 1  Level 2  Level 3  Level 1  Level 2  Level 3 
Assets                  
None  -   -   -   -   -   - 
Total assets  -   -   -   -   -   - 
Liabilities                        
Option derivative liability  -   -   115,000   -   -   90,000 
Total liabilities $-  $-  $115,000  $-  $-  $90,000 
Schedule of reconciliation of changes in fair value of derivative liabilities classified as Level 3
  Significant Unobservable
Inputs
(Level 3)
as of
September 30, 2018
 
Beginning balance $90,000 
Change in fair value  25,000 
Ending balance $115,000 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2018
Stock options [Member]  
Schedule of outstanding stock warrants and options
  Number of Options
(#)
  Weighted Average Exercise
Price ($)
  Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017  50,000,000   0.03   2.75 
Granted  -   -   - 
Exercised  -   -   - 
Expired  -   -   - 
Cancelled  -   -   - 
Balance – September 30, 2018  50,000,000   0.03   2.00 
Warrants [Member]  
Schedule of outstanding stock warrants and options
  Number of Warrants
(#)
  Weighted Average Exercise
Price ($)
  Weighted Average Remaining Contractual Life (Years) 
Balance - December 31, 2017  65,000,000   0.004   0.17 
Granted  -   -   - 
Cancelled  -   -   - 
Expired  65,000,000   0.004   - 
Exercised  -   -   - 
Balance – September 30, 2018  -   -   - 
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2018
Intangible Assets [Abstract]  
Summary of intangible assets
        Weighted
average
 
  September 30,  December 31,  amortization
period
 
  2018  2017  (years) 
Patents $4,020,000  $4,000,000   9.8 
Less: net monetization obligations  (509,811)  (509,811)    
Imputed interest  (376,291)  (376,291)    
Subtotal  3,133,898   3,113,898     
Less: accumulated amortization  (983,850)  (650,560)    
Net value of intangible assets $2,150,048  $2,463,338   8.2 
Summary of annual amortization expense
Year ended December 31,   
2018 $104,430 
2019  417,719 
2020  417,719 
2021  413,658 
2022 and thereafter  796,522 
Total $2,150,048 
Schedule of purchase price of the patents
  September 30,
2018
  December 31, 
2017
 
Current Liabilities:      
Purchase price of patents, current portion  100,000  $100,000 
Unamortized discount        
Non-current liabilities:        
Purchase price of patents, long term  875,000  $875,000 
Unamortized discount  (123,321)  (175,243)
Total current and non-current  851,679   799,757 
Effective interest rate of Amortized over 2-3 years      9.2-9.6%
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-Controlling Interest (Tables)
9 Months Ended
Sep. 30, 2018
Non-Controlling Interest [Abstract]  
Schedule of equity attributable to the non-controlling interest
Balance as of December 31, 2017 $3,219 
Net income attributable to non-controlling interest $(1,511)
Balance as of September 30, 2018 $1,708 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Summary of Significant Accounting Policies (Textual)          
Cash received $ 250,000   $ 250,000    
Accumulated deficit (17,819,990)   (17,819,990)   $ (16,549,493)
Negative working capital     5,097,000    
Foreign income tax expenses 0 $ 170 1,040,000 $ 105,000  
Short-term debt $ 4,253,944   $ 4,253,944   $ 3,595,926
Quest Packaging Solutions Corporation [Member]          
Summary of Significant Accounting Policies (Textual)          
Ownership percentage 90.00%   90.00%    
Wynn Technologies Inc. [Member]          
Summary of Significant Accounting Policies (Textual)          
Ownership description     Wynn Technologies Inc. cannot transfer, assign, sell, hypothecate or otherwise encumber US Patent No. RE38,173E without the express written consent of Sol Li, owner of 35% of Wynn Technologies Inc., unless, as of the date of such transfer, assignment, sale, hypothecation or other encumbrance, Mr. Li has received a total of at least $250,000.    
Ownership percentage 65.00%   65.00%    
Contribution percentage     60.00%    
Percentage of income retained     40.00%    
Distribution percentage     60.00%    
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Short-Term Debt and Long Term Liabilities (Details) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Short-term debt:    
Loans payable - third party $ 163,000 $ 163,000
Loan payable - related party    
Gross 4,277,351 4,027,351
Accrued Interest 395,459 85,757
Unamortized discount (418,866) (517,182)
Net loans payable - related party 4,253,944 3,595,926
Total short-term debt 4,916,944 3,758,926
Purchase price of patents    
Gross 875,000 875,000
Unamortized discount (123,321) (175,243)
Net purchase price of patents - long-term $ 751,679 $ 699,757
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Short-Term Debt and Long Term Liabilities (Details Textual) - USD ($)
9 Months Ended
Jun. 12, 2017
Sep. 30, 2018
Dec. 31, 2017
Jun. 15, 2017
Short-Term Debt and Long-Term Liabilities (Textual)        
Loans payable - third party   $ 163,000 $ 163,000  
Accrued interest   10.00%    
Common stock, shares authorized   10,000,000,000 10,000,000,000  
Percentage of distribute net recoveries   50.00%    
CXT advanced of recoveries   $ 25,000    
Cumulative distributions August 31, 2018   100,000    
Cumulative distributions August 31, 2019   375,000    
Cumulative distributions August 31, 2020   $ 975,000    
United Wireless Holdings, Inc. [Member]        
Short-Term Debt and Long-Term Liabilities (Textual)        
Percentage of note   10.00%    
Securities Purchase Agreement [Member] | United Wireless Holdings, Inc. [Member]        
Short-Term Debt and Long-Term Liabilities (Textual)        
Principal amount   $ 4,277,351    
Common stock, shares authorized       10,000,000,000
Standstill Agreement [Member]        
Short-Term Debt and Long-Term Liabilities (Textual)        
Principal amount   $ 25,000    
Promissory note due date   Sep. 30, 2020    
Percentage of promissory note   10.00%    
Company received amount   $ 25,000    
Payment to IV 34/37 referred   $ 25,000    
Percentage of net monetization   7.50%    
Standstill Agreement [Member] | United Wireless Holdings, Inc. [Member]        
Short-Term Debt and Long-Term Liabilities (Textual)        
Debt instrument, description On June 12, 2017, the Company entered into a standstill agreement with United Wireless pursuant to which the Company agreed (i) to increase its authorized common stock to 10,000,000,000 shares, (ii) to file by June 30, 2017, a post-effective amendment to the registration statement covering the sale of the shares of common stock initially issued to United Wireless pursuant to the securities purchase agreement and the shares of common stock issuable upon the option granted to United Wireless pursuant to the securities purchase agreement, (iii) if the existing warrant held by the Company's chief executive officer is not exercised prior to its expiration date, any re-issuance will not have an exercise price less than the current exercise price and the existing warrants will not be amended to lower the exercise price, and (iv) United Wireless no longer has any obligation to purchase any note pursuant to the securities purchase agreement other than the $1,000,000 note related to the final payment to Intellectual Ventures which was made in November 2017, except in connection with the potential acquisition by the Company of patent rights which triggered a $25,000 working capital loan in connection with the acquisition and the Company can require United Wireless to make $125,000 working capital loans to the Company, at the Company's sole discretion, on December 31, 2017, March 31, 2018 and June 30, 2018 pursuant to the securities purchase agreement dated October 22, 2015 more fully described in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 and, in such event, United Wireless would have a 7.5% net proceeds percentage interest in the net proceeds from such patent.      
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities (Details)
9 Months Ended
Sep. 30, 2018
Derivative [Line Items]  
Risk-free interest rate 1.36%
Expected dividends
Maximum [Member]  
Derivative [Line Items]  
Volatility 460.00%
Expected term 2 years 9 months
Minimum [Member]  
Derivative [Line Items]  
Volatility 417.00%
Expected term 2 years
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities (Details 1) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Fair Value Measurements as of Level 1 [Member]    
Assets    
None
Total assets
Liabilities    
Option derivative liability
Total liabilities
Fair Value Measurements as of Level 2 [Member]    
Assets    
None
Total assets
Liabilities    
Option derivative liability
Total liabilities
Fair Value Measurements as of Level 3 [Member]    
Assets    
None
Total assets
Liabilities    
Option derivative liability 115,000 90,000
Total liabilities $ 115,000 $ 90,000
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities (Details 2) - Significant Unobservable Inputs (Level 3) [Member]
9 Months Ended
Sep. 30, 2018
USD ($)
Derivative [Line Items]  
Beginning balance $ 90,000
Change in fair value 25,000
Ending balance $ 115,000
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Liabilities (Details Textual) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Derivative Liabilities (Textual)    
Aggregate fair value of outstanding derivative liability $ 115,000 $ 90,000
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details ) - Stock Options [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Number of Options    
Beginning Balance 50,000,000  
Granted  
Exercised  
Expired  
Cancelled  
Ending Balance 50,000,000 50,000,000
Weighted Average Exercise Price    
Beginning Balance $ 0.03  
Granted  
Exercised  
Expired  
Cancelled  
Ending Balance $ 0.03 $ 0.03
Weighted Average Remaining Contractual Life (Years)    
Weighted Average Remaining Contractual Life (Years) 2 years 2 years 9 months
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details 1) - Warrants [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Number of Warrants    
Beginning Balance 65,000,000  
Granted  
Cancelled  
Expired 65,000,000  
Exercised  
Ending Balance 65,000,000
Weighted Average Exercise Price    
Beginning Balance $ 0.004  
Granted  
Cancelled  
Expired 0.004  
Exercised  
Ending Balance $ 0.004
Weighted Average Remaining Contractual Life (Years)    
Weighted Average Remaining Contractual Life (Years) 0 years 2 months 1 day
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Details) - USD ($)
9 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Summary of intangible assets    
Patents $ 4,020,000 $ 4,000,000
Less: net monetization obligations (509,811) (509,811)
Imputed interest (376,291) (376,291)
Subtotal 3,133,898 3,113,898
Less: accumulated amortization (983,850) (650,560)
Net value of intangible assets $ 2,150,048 $ 2,463,338
Weighted average amortization period (years) 8 years 2 months 12 days  
Patents [Member]    
Summary of intangible assets    
Weighted average amortization period (years) 9 years 9 months 18 days  
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Details 1) - Patents [Member]
Sep. 30, 2018
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
2018 $ 104,430
2019 417,719
2020 417,719
2021 413,658
2022 and thereafter 796,522
Total $ 2,150,048
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2017
Sep. 30, 2018
Current Liabilities:    
Purchase price of patents, current portion $ 100,000 $ 100,000
Non-current liabilities:    
Unamortized discount (175,243) (123,321)
Patents [Member]    
Current Liabilities:    
Purchase price of patents, current portion 100,000 100,000
Unamortized discount
Non-current liabilities:    
Purchase price of patents, long term 875,000 875,000
Unamortized discount (175,243) (123,321)
Total current and non-current $ 799,757 $ 851,679
Patents [Member] | Maximum [Member]    
Non-current liabilities:    
Effective interest rate of Amortized over 2-3 years 9.60%  
Patents [Member] | Minimum [Member]    
Non-current liabilities:    
Effective interest rate of Amortized over 2-3 years 9.20%  
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Details Textual) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2015
Sep. 30, 2018
Dec. 31, 2017
Intangible Assets (Textual)      
Cumulative distributions August 31, 2020   $ 975,000  
Cumulative distributions August 31, 2019   375,000  
Cumulative distributions August 31, 2018   $ 100,000  
Percentage of distribute net revenues   50.00%  
Book value of intellectual property   $ 2,150,048 $ 2,463,338
Amortization expense   $ 333,290 $ 331,275
Percentage of patents acquired 15.00% 7.50%  
Imputed interest   10.00%  
Non-current minimum payment obligations   $ 875,000  
Description of due term   Due over the next three years.  
Patents [Member]      
Intangible Assets (Textual)      
Intangible assets, description   (1) patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years, (2) patents acquired in July 2017 pursuant to an obligation to distribute 50% of net revenues to IV 34/37, against which $25,000 was advanced at closing and provided that in the event that, on December 31, 2018, December 31, 2019 and December 31, 2020, cumulative distributions of 50% of net revenues to IV 34/37 total less than $100,000, $375,000 and $975,000, respectively, CXT shall pay the difference necessary to achieve the applicable minimum payment amount within ten days after the applicable date; with any advances being credited toward future distributions to IV 34/37; the useful lives of the patents, at the date of acquisition, was 5-6 years, (3) patents (which were fully depreciated at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC "(IV 62/71"), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71 against which CXT advanced $10,000 at closing; and (4) patents acquired in January 2018 by Photonic Imaging Solutions Inc. ("PIS") from Intellectual Ventures Assets 64 LLC ("IV 64") pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000, against which PIS advanced $10,000 at closing.  
Patents [Member] | Maximum [Member]      
Intangible Assets (Textual)      
Patents useful lives   10 years  
Effective interest rate of amortized periods   3 years  
Patents [Member] | Minimum [Member]      
Intangible Assets (Textual)      
Patents useful lives   6 years  
Effective interest rate of amortized periods   2 years  
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-Controlling Interest (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Non-Controlling Interest [Abstract]        
Balance as of December 31, 2017     $ 3,219  
Net income (loss) attributable to non-controlling interest in subsidiaries $ 485 $ 21 1,511 $ (1,190)
Balance as of March 31, 2018 $ 1,708   $ 1,708  
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Related Party Transactions (Textual)        
Cost of information technology services $ 205 $ 205 $ 625 $ 850
Interest expense $ 108,000 $ 72,000 $ 310,000 $ 208,000
United Wireless Holdings, Inc. [Member]        
Related Party Transactions (Textual)        
Percentage of note     10.00%  
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 9 Months Ended
Nov. 30, 2014
Aug. 31, 2016
Mar. 31, 2016
Sep. 30, 2018
Commitments and Contingencies (Textual)        
Litigation fees, costs and expenses       $ 3,000,000
Chief executive officer [Member]        
Commitments and Contingencies (Textual)        
Term of agreement, Description The Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days' notice prior to the expiration of the initial term or any one-year extension.      
Annual salary     $ 300,000  
Annual bonus compensation, Description   The Company's board of directors approved annual bonus compensation equal to 30% of the amount by which the Company's consolidated income before income taxes exceeds $500,000.    
EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 48 199 1 false 14 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.questproduct.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Unaudited Consolidated Balance Sheets Sheet http://www.questproduct.com/role/UnauditedConsolidatedBalanceSheets Unaudited Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) Sheet http://www.questproduct.com/role/UnauditedConsolidatedBalanceSheetsParenthetical Unaudited Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Unaudited Consolidated Statement of Operations Sheet http://www.questproduct.com/role/UnauditedConsolidatedStatementOfOperations Unaudited Consolidated Statement of Operations Statements 4 false false R5.htm 005 - Statement - Unaudited Consolidated Statement of Cash Flows Sheet http://www.questproduct.com/role/UnauditedConsolidatedStatementOfCashFlows Unaudited Consolidated Statement of Cash Flows Statements 5 false false R6.htm 006 - Statement - Unaudited Consolidated Statement of Cash Flows (Parenthetical) Sheet http://www.questproduct.com/role/UnauditedConsolidatedStatementOfCashFlowsParenthetical Unaudited Consolidated Statement of Cash Flows (Parenthetical) Statements 6 false false R7.htm 007 - Disclosure - Description of Business and Basis of Presentation Sheet http://www.questproduct.com/role/DescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 7 false false R8.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.questproduct.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 009 - Disclosure - Short-Term Debt and Long Term Liabilities Sheet http://www.questproduct.com/role/ShortTermDebtAndLongTermLiabilities Short-Term Debt and Long Term Liabilities Notes 9 false false R10.htm 010 - Disclosure - Derivative Liabilities Sheet http://www.questproduct.com/role/DerivativeLiabilities Derivative Liabilities Notes 10 false false R11.htm 011 - Disclosure - Stockholders' Equity Sheet http://www.questproduct.com/role/StockholdersEquity Stockholders' Equity Notes 11 false false R12.htm 012 - Disclosure - Intangible Assets Sheet http://www.questproduct.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 013 - Disclosure - Non-Controlling Interest Sheet http://www.questproduct.com/role/NonControllingInterest Non-Controlling Interest Notes 13 false false R14.htm 014 - Disclosure - Related Party Transactions Sheet http://www.questproduct.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 015 - Disclosure - Commitments and Contingencies Sheet http://www.questproduct.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.questproduct.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.questproduct.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 017 - Disclosure - Short-Term Debt and Long Term Liabilities (Tables) Sheet http://www.questproduct.com/role/Shorttermdebtandlongtermliabilitiestables Short-Term Debt and Long Term Liabilities (Tables) Tables http://www.questproduct.com/role/ShortTermDebtAndLongTermLiabilities 17 false false R18.htm 018 - Disclosure - Derivative Liabilities (Tables) Sheet http://www.questproduct.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://www.questproduct.com/role/DerivativeLiabilities 18 false false R19.htm 019 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.questproduct.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.questproduct.com/role/StockholdersEquity 19 false false R20.htm 020 - Disclosure - Intangible Assets (Tables) Sheet http://www.questproduct.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.questproduct.com/role/IntangibleAssets 20 false false R21.htm 021 - Disclosure - Non-Controlling Interest (Tables) Sheet http://www.questproduct.com/role/NonControllingInterestTables Non-Controlling Interest (Tables) Tables http://www.questproduct.com/role/NonControllingInterest 21 false false R22.htm 022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.questproduct.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.questproduct.com/role/SummaryofSignificantAccountingPoliciesPolicies 22 false false R23.htm 023 - Disclosure - Short-Term Debt and Long Term Liabilities (Details) Sheet http://www.questproduct.com/role/ShortTermDebtAndLongTermLiabilitiesDetails Short-Term Debt and Long Term Liabilities (Details) Details http://www.questproduct.com/role/Shorttermdebtandlongtermliabilitiestables 23 false false R24.htm 024 - Disclosure - Short-Term Debt and Long Term Liabilities (Details Textual) Sheet http://www.questproduct.com/role/ShortTermDebtAndLongTermLiabilitiesDetailsTextual Short-Term Debt and Long Term Liabilities (Details Textual) Details http://www.questproduct.com/role/Shorttermdebtandlongtermliabilitiestables 24 false false R25.htm 025 - Disclosure - Derivative Liabilities (Details) Sheet http://www.questproduct.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) Details http://www.questproduct.com/role/DerivativeLiabilitiesTables 25 false false R26.htm 026 - Disclosure - Derivative Liabilities (Details 1) Sheet http://www.questproduct.com/role/DerivativeLiabilitiesDetails1 Derivative Liabilities (Details 1) Details http://www.questproduct.com/role/DerivativeLiabilitiesTables 26 false false R27.htm 027 - Disclosure - Derivative Liabilities (Details 2) Sheet http://www.questproduct.com/role/DerivativeLiabilitiesDetails2 Derivative Liabilities (Details 2) Details http://www.questproduct.com/role/DerivativeLiabilitiesTables 27 false false R28.htm 028 - Disclosure - Derivative Liabilities (Details Textual) Sheet http://www.questproduct.com/role/DerivativeLiabilitiesDetailsTextual Derivative Liabilities (Details Textual) Details http://www.questproduct.com/role/DerivativeLiabilitiesTables 28 false false R29.htm 029 - Disclosure - Stockholders' Equity (Details ) Sheet http://www.questproduct.com/role/Stockholdersequitydetails Stockholders' Equity (Details ) Details http://www.questproduct.com/role/StockholdersEquityTables 29 false false R30.htm 030 - Disclosure - Stockholders' Equity (Details 1) Sheet http://www.questproduct.com/role/Stockholdersequitydetails1 Stockholders' Equity (Details 1) Details http://www.questproduct.com/role/StockholdersEquityTables 30 false false R31.htm 031 - Disclosure - Intangible Assets (Details) Sheet http://www.questproduct.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.questproduct.com/role/IntangibleAssetsTables 31 false false R32.htm 032 - Disclosure - Intangible Assets (Details 1) Sheet http://www.questproduct.com/role/IntangibleAssetsDetails1 Intangible Assets (Details 1) Details http://www.questproduct.com/role/IntangibleAssetsTables 32 false false R33.htm 033 - Disclosure - Intangible Assets (Details 2) Sheet http://www.questproduct.com/role/IntangibleAssetsDetails2 Intangible Assets (Details 2) Details http://www.questproduct.com/role/IntangibleAssetsTables 33 false false R34.htm 034 - Disclosure - Intangible Assets (Details Textual) Sheet http://www.questproduct.com/role/IntangibleAssetsDetailsTextual Intangible Assets (Details Textual) Details http://www.questproduct.com/role/IntangibleAssetsTables 34 false false R35.htm 035 - Disclosure - Non-Controlling Interest (Details) Sheet http://www.questproduct.com/role/NonControllingInterestDetails Non-Controlling Interest (Details) Details http://www.questproduct.com/role/NonControllingInterestTables 35 false false R36.htm 036 - Disclosure - Related Party Transactions (Details) Sheet http://www.questproduct.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.questproduct.com/role/RelatedPartyTransactions 36 false false R37.htm 037 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.questproduct.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.questproduct.com/role/CommitmentsAndContingencies 37 false false All Reports Book All Reports qprc-20180930.xml qprc-20180930.xsd qprc-20180930_cal.xml qprc-20180930_def.xml qprc-20180930_lab.xml qprc-20180930_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 53 0001213900-18-015708-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-18-015708-xbrl.zip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